<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75718</article-id><article-id pub-id-type="doi">10.7554/eLife.75718</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Oxytocin signaling in the posterior hypothalamus prevents hyperphagic obesity in mice</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-262504"><name><surname>Inada</surname><given-names>Kengo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0859-4582</contrib-id><email>k.inada.repository@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289869"><name><surname>Tsujimoto</surname><given-names>Kazoku</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262506"><name><surname>Yoshida</surname><given-names>Masahide</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1247-2294</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-186185"><name><surname>Nishimori</surname><given-names>Katsuhiko</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-266284"><name><surname>Miyamichi</surname><given-names>Kazunari</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7807-8436</contrib-id><email>kazunari.miyamichi@riken.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="fn1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/023rffy11</institution-id><institution>RIKEN Center for Biosystems Dynamics Research</institution></institution-wrap><addr-line><named-content content-type="city">Kobe</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01dq60k83</institution-id><institution>Laboratory of Molecular Biology, Department of Molecular and Cell Biology, Graduate School of Agricultural Science, Tohoku University</institution></institution-wrap><addr-line><named-content content-type="city">Sendai</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010hz0g26</institution-id><institution>Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Shimotsuke</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012eh0r35</institution-id><institution>Department of Obesity and Inflammation Research, Fukushima Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Fukushima</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00097mb19</institution-id><institution>CREST, Japan Science and Technology Agency</institution></institution-wrap><addr-line><named-content content-type="city">Kawaguchi</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Elmquist</surname><given-names>Joel K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wong</surname><given-names>Ma-Li</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040kfrw16</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="other" id="fn1"><label>†</label><p>Lead Contact</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>25</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e75718</elocation-id><history><date date-type="received" iso-8601-date="2021-11-20"><day>20</day><month>11</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-10-12"><day>12</day><month>10</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-12-01"><day>01</day><month>12</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.11.29.470473"/></event></pub-history><permissions><copyright-statement>© 2022, Inada et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Inada et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75718-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-75718-figures-v1.pdf"/><abstract><p>Decades of studies have revealed molecular and neural circuit bases for body weight homeostasis. Neural hormone oxytocin (Oxt) has received attention in this context because it is produced by neurons in the paraventricular hypothalamic nucleus (PVH), a known output center of hypothalamic regulation of appetite. Oxt has an anorexigenic effect, as shown in human studies, and can mediate satiety signals in rodents. However, the function of Oxt signaling in the physiological regulation of appetite has remained in question, because whole-body knockout (KO) of <italic>Oxt</italic> or <italic>Oxt receptor</italic> (<italic>Oxtr</italic>) has little effect on food intake. We herein show that acute conditional KO (cKO) of <italic>Oxt</italic> selectively in the adult PVH, but not in the supraoptic nucleus, markedly increases body weight and food intake, with an elevated level of plasma triglyceride and leptin. Intraperitoneal administration of Oxt rescues the hyperphagic phenotype of the PVH <italic>Oxt</italic> cKO model. Furthermore, we show that cKO of <italic>Oxtr</italic> selectively in the posterior hypothalamic regions, especially the arcuate hypothalamic nucleus, a primary center for appetite regulations, phenocopies hyperphagic obesity. Collectively, these data reveal that Oxt signaling in the arcuate nucleus suppresses excessive food intake.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>oxytocin</kwd><kwd>oxytocin receptor</kwd><kwd>hyperphagic obesity</kwd><kwd>leptin</kwd><kwd>conditional knockout</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>KAKENHI 19J00403</award-id><principal-award-recipient><name><surname>Inada</surname><given-names>Kengo</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>KAKENHI 19K16303</award-id><principal-award-recipient><name><surname>Inada</surname><given-names>Kengo</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002241</institution-id><institution>Japan Science and Technology Agency</institution></institution-wrap></funding-source><award-id>CREST JPMJCR2021</award-id><principal-award-recipient><name><surname>Miyamichi</surname><given-names>Kazunari</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>KAKENHI 20K20589</award-id><principal-award-recipient><name><surname>Miyamichi</surname><given-names>Kazunari</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Conditional knockout mice revealed that oxytocin secretion from the paraventricular hypothalamic nucleus suppresses hyperphagic obesity partly via the oxytocin receptor expressed in the arcuate hypothalamic nucleus.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Appetite is one of the strongest desires in animals. The consumption of nutritious foods is a primitive pleasure for animals because it is essential for survival. Yet, excessive food intake leads to obesity and increases the risk of disease. Understanding the neurobiological bases of appetite regulation is therefore an urgent issue, given that the body mass index of humans has increased dramatically over the last 40 years (<xref ref-type="bibr" rid="bib30">NCD Risk Factor Collaboration, 2016</xref>).</p><p>Decades of studies in rodents have revealed molecular and neural circuit bases for body weight homeostasis (<xref ref-type="bibr" rid="bib1">Andermann and Lowell, 2017</xref>; <xref ref-type="bibr" rid="bib43">Sternson and Eiselt, 2017</xref>; <xref ref-type="bibr" rid="bib44">Sutton et al., 2016</xref>). Classical studies with mechanical or electrical lesioning, as well as recent molecular or genetic dissections, both support the critical roles of appetite regulation by neurons in the arcuate hypothalamic nucleus (ARH), in particular, those expressing orexigenic agouti-related protein (Agrp) and anorexigenic pre-opiomelanocortin (Pomc) (<xref ref-type="bibr" rid="bib10">Choi et al., 1999</xref>; <xref ref-type="bibr" rid="bib32">Ollmann et al., 1997</xref>). These neurons receive both direct humoral inputs and neural inputs of interoception (<xref ref-type="bibr" rid="bib4">Bai et al., 2019</xref>) to regulate food intake antagonistically at various timescales (<xref ref-type="bibr" rid="bib19">Krashes et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Sternson and Eiselt, 2017</xref>). The paraventricular hypothalamic nucleus (PVH) is one of the critical output structures of the primary appetite-regulating ARH neurons. Silencing PVH neurons phenocopies the overeating effect observed in the activation of Agrp neurons, whereas activating PVH neurons ameliorates the overeating caused by the acute activation of Agrp neurons (<xref ref-type="bibr" rid="bib3">Atasoy et al., 2012</xref>; <xref ref-type="bibr" rid="bib14">Garfield et al., 2015</xref>). Melanocortin-4 receptor (MC4R)-expressing neurons in the PVH are the key target of ARH Agrp and Pomc neurons. PVH MC4R neurons are activated by α-melanocyte-stimulating hormone provided by Pomc neurons and inhibited by GABAergic Agrp neurons, and are supposed to transmit signals to the downstream target regions in the midbrain and pons (<xref ref-type="bibr" rid="bib14">Garfield et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Stachniak et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Sutton et al., 2016</xref>).</p><p>Although PVH MC4R neurons have been relatively well documented (<xref ref-type="bibr" rid="bib5">Balthasar et al., 2005</xref>; <xref ref-type="bibr" rid="bib14">Garfield et al., 2015</xref>), other PVH cell types may also mediate output signals to control feeding and energy expenditure (<xref ref-type="bibr" rid="bib44">Sutton et al., 2016</xref>). However, little is known about the organization, cell types, and neurotransmitters by which appetite-regulating signals are conveyed to other brain regions. Neural hormone oxytocin (Oxt), which marks one of the major cell types in the PVH, has received attention in this context (<xref ref-type="bibr" rid="bib24">Leng and Sabatier, 2017</xref>; <xref ref-type="bibr" rid="bib33">Onaka and Takayanagi, 2019</xref>). The anorexigenic effect of Oxt has been shown in humans (<xref ref-type="bibr" rid="bib20">Lawson et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Thienel et al., 2016</xref>), and genetic variations of <italic>Oxt receptor</italic> (<italic>Oxtr</italic>) have been implicated as a risk factor of overeating (<xref ref-type="bibr" rid="bib9">Çatli et al., 2021</xref>; <xref ref-type="bibr" rid="bib11">Davis et al., 2017</xref>). In rodents, Oxt administration has been shown to suppress increases in food intake and body weight (<xref ref-type="bibr" rid="bib28">Maejima et al., 2018</xref>). Pons-projecting Oxt neurons have been shown to be active following leptin administration (<xref ref-type="bibr" rid="bib6">Blevins et al., 2004</xref>), and knockdown of <italic>Oxtr</italic> in the nucleus of the solitary tract has been reported to alter feeding patterns (<xref ref-type="bibr" rid="bib34">Ong et al., 2017</xref>). In addition, <italic>Oxtr</italic>-expressing neurons in the ARH have been shown to evoke acute appetite suppression signals when opto- or chemo-genetically activated (<xref ref-type="bibr" rid="bib13">Fenselau et al., 2017</xref>). Despite the importance of the Oxt-OxtR system in the food intake and homeostasis of body weight (<xref ref-type="bibr" rid="bib28">Maejima et al., 2018</xref>), knockout (KO) and ablation studies still question such findings (<xref ref-type="bibr" rid="bib44">Sutton et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Worth and Luckman, 2021</xref>). For example, <italic>Oxt</italic> or <italic>Oxtr</italic> KO mice showed increased body weight at around 4 months of age (termed late-onset obesity), while their food intake was not different from that of wild-type mice (<xref ref-type="bibr" rid="bib7">Camerino, 2009</xref>; <xref ref-type="bibr" rid="bib46">Takayanagi et al., 2008</xref>). Diphtheria toxin-based genetic ablation of <italic>Oxt</italic>-expressing cells in adult mice increased the body weight of male mice with a high-fat diet, but not those with normal chow, and in both cases, food intake was unaffected (<xref ref-type="bibr" rid="bib52">Wu et al., 2012b</xref>). To revisit the function and sites of action of Oxt signaling in the regulation of feeding, acute conditional KO (cKO) mouse models would be useful.</p><p>Here, we describe <italic>Oxt</italic> cKO phenotypes related to hyperphagic obesity. Our approach offers the following two advantages over previous studies: (i) the <italic>Oxt</italic> gene can be knocked out in adult mice, avoiding the influence of possible developmental and genetic compensations (<xref ref-type="bibr" rid="bib12">El-Brolosy et al., 2019</xref>); and (ii) the manipulation can be restricted to the brain, or even to a single hypothalamic nucleus, providing a resolution that exceeds previous studies. Owing to these advantages, we show that <italic>Oxt</italic> cKO increases both body weight and food intake. The suppression of overeating and overweighting is predominantly regulated by Oxt neurons in the PVH, leaving Oxt neurons in the supraoptic nucleus (SO) with only a minor role. We further show that <italic>Oxtr</italic>-expressing neurons in the posterior part of the hypothalamus, especially the ARH, mediate the overeating-suppression signals generated by Oxt neurons.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>cKO of PVH <italic>Oxt</italic> increases body weight and food intake</title><p>To examine the necessity of <italic>Oxt</italic> for the regulation of food intake, we prepared recently validated <italic>Oxt<sup>flox/flox</sup></italic> mice (<xref ref-type="bibr" rid="bib15">Inada et al., 2022</xref>). In this line, Cre expression deletes floxed exon 1 of the <italic>Oxt</italic> gene, resulting in the loss of transcription of <italic>Oxt</italic> mRNA (<xref ref-type="bibr" rid="bib15">Inada et al., 2022</xref>). To perform the cKO in PVH Oxt neurons, we first crossed <italic>Oxt<sup>flox/flox</sup></italic> and <italic>Oxt</italic> KO (<italic>Oxt<sup>–/–</sup></italic>) mice and obtained <italic>Oxt<sup>flox/–</sup></italic> mice. Then, we injected <italic>AAV-Cre</italic> into the bilateral PVH of 8-week-old <italic>Oxt<sup>flox/–</sup></italic> male mice (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). The number of neurons expressing <italic>Oxt</italic>, visualized by in situ hybridization (ISH), significantly decreased within 3 weeks after the <italic>AAV-Cre</italic> injection (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The body weight of <italic>Oxt<sup>flox/–</sup></italic> mice that received <italic>AAV-Cre</italic> injection started to deviate from the controls at around 3 weeks after the injection (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). At 5 weeks after the injection, we compared the body weight of <italic>Oxt<sup>flox/–</sup></italic> mice that received <italic>AAV-Cre</italic> injection with the wild-type (<italic>Oxt<sup>+/+</sup></italic>), <italic>Oxt<sup>–/–</sup>,</italic> and <italic>Oxt<sup>flox/–</sup></italic> mice that received vehicle injection. We found that <italic>AAV-Cre</italic>-injected <italic>Oxt<sup>flox/–</sup></italic> mice were heavier than those in the other groups (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>). Importantly, this increase in body weight was considered unlikely to be a reflection of late-onset obesity, as previously reported (<xref ref-type="bibr" rid="bib7">Camerino, 2009</xref>; <xref ref-type="bibr" rid="bib46">Takayanagi et al., 2008</xref>), because we did not find a significant difference between the wild-type and <italic>Oxt<sup>–/–</sup></italic> mice (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Next, we analyzed the relationship between the number of remaining <italic>Oxt</italic>+ neurons and body weight. We found that mice with a fewer number of remaining <italic>Oxt</italic>+ neurons showed a heavier body weight (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). We also found an increase in food intake: the daily food intake of <italic>Oxt<sup>flox/–</sup></italic> mice that received <italic>AAV-Cre</italic> injection was significantly larger at &gt;4 weeks after the injection (<xref ref-type="fig" rid="fig1">Figure 1H</xref>), and the total food intake during the 5 weeks after the injection was also larger in the mice that received <italic>AAV-Cre</italic> injection (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). Of note, these effects are not due to the nonspecific toxicity of <italic>AAV-Cre</italic> injection per se, as <italic>AAV-Cre</italic> injection to wild-type mice did not alter body weight or daily food intake (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–D</xref>). These results demonstrate that the cKO of <italic>Oxt</italic> evokes increases in both body weight and food intake.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Oxytocin (Oxt)</italic> conditional knockout (cKO) in paraventricular hypothalamic nucleus (PVH) induces an increase in body weight and food intake.</title><p>(<bold>A</bold>) Schematic of the virus injection. <italic>AAV-Cre</italic> or vehicle was injected into the bilateral PVH of <italic>Oxt<sup>flox/–</sup></italic> male mice. (<bold>B</bold>) Representative coronal sections of the PVH from <italic>Oxt<sup>flox/–</sup></italic> mice received vehicle (left) or <italic>AAV-Cre</italic> (right) injection. Data were obtained at 5 weeks after the injection. Magenta and green represent <italic>Oxt</italic> and <italic>Cre</italic> in situ stainings, respectively. Blue, DAPI. Scale bar, 50 μm. (<bold>C</bold>) The number of remaining <italic>Oxt</italic>+ neurons in the PVH of mice that received <italic>AAV-Cre</italic> injection. **p&lt;0.01, one-way ANOVA with post hoc Tukey’s HSD. N=5 each. (<bold>D</bold>) Time course of body weight after <italic>AAV-Cre</italic> or vehicle injection. N=6 each. (<bold>E</bold>) Representative photos of <italic>Oxt<sup>flox/–</sup></italic> mice that received either vehicle (left) or <italic>AAV-Cre</italic> injection (right). Five weeks after the injection. Scale bar, 5 cm. (<bold>F</bold>) Body weight of wild-type (<italic>+/+</italic>), <italic>Oxt</italic> KO (<italic>–/–</italic>), and <italic>Oxt</italic> cKO (<italic>flox/–</italic>) mice. The weight was measured at 5 weeks after injection of either vehicle or <italic>AAV-Cre</italic>. Note that this time point corresponds to 13 weeks of age. **p&lt;0.01, one-way ANOVA with post hoc Tukey’s HSD. N=10, 7, 9, and 10 for <italic>+/+</italic>, <italic>–/–</italic>, <italic>flox/–</italic> vehicle, and <italic>flox/–</italic> Cre, respectively. (<bold>G</bold>) Relationship between the number of remaining <italic>Oxt</italic>+ neurons in the PVH and the body weight of <italic>Oxt<sup>flox/–</sup></italic> mice shown in (<bold>F</bold>). Magenta, exponential fit for the data from both Cre and vehicle. (<bold>H</bold>) Time course of daily food intake, defined as the average food intake in each week after <italic>AAV-Cre</italic> or vehicle injection. ***p&lt;0.001, Student’s <italic>t</italic>-test with post hoc Bonferroni correction. N=6 each. (<bold>I</bold>) Cumulative food intake during the 5 weeks after the injection. ***p&lt;0.001, Student’s <italic>t</italic>-test. N=6 each.</p><p>Error bars, standard error of mean (SEM).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>AAV-Cre</italic> injection into the paraventricular hypothalamic nucleus (PVH) of wild-type mice does not induce hyperphagic obesity.</title><p>(<bold>A</bold>) Schematic of the virus injection. <italic>AAV-Cre</italic> or vehicle was injected into the bilateral PVH of wild-type male mice. (<bold>B</bold>) Representative coronal section of the left PVH from wild-type mice that had received <italic>AAV-Cre</italic> injection. Data were obtained at 5 weeks after the injection. Green, <italic>Cre</italic> in situ staining, blue, DAPI. Scale bar, 50 μm. (<bold>C</bold>) Body weight measured at 5 weeks after the injection was not statistically different (p&gt;0.82, Student’s <italic>t</italic>-test). N=10 each. (<bold>D</bold>) Daily food intake measured at 5 weeks after the injection (p&gt;0.59, Student’s <italic>t</italic>-test). Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig1-figsupp1-v1.tif"/></fig></fig-group><p>In addition to the PVH, Oxt neurons are also clustered in the SO (<xref ref-type="bibr" rid="bib55">Zhang et al., 2021</xref>). To examine whether Oxt neurons in the SO also play inhibitory roles on body weight and food intake, we injected <italic>AAV-Cre</italic> into the bilateral SO of <italic>Oxt<sup>flox/–</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). Similar to the PVH, the number of <italic>Oxt+</italic> neurons in the SO significantly decreased at around 3 weeks after the injection (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Unlike the PVH, however, neither body weight nor food intake was significantly different compared with controls (<xref ref-type="fig" rid="fig2">Figure 2D–G</xref>), and no clear relationship was found between the number of the remaining <italic>Oxt+</italic> neurons and body weight (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). These results suggest that PVH Oxt neurons predominantly regulate food intake and body weight, and that SO Oxt neurons exert little influence.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Oxytocin (Oxt)</italic> conditional knockout (cKO) in supraoptic nucleus (SO) has a negligible effect on food intake and body weight.</title><p>(<bold>A</bold>) Schematic of the virus injection. <italic>AAV-Cre</italic> or vehicle was injected into the bilateral SO of <italic>Oxt<sup>flox/–</sup></italic> male mice. (<bold>B</bold>) Representative coronal sections of left SO from <italic>Oxt<sup>flox/–</sup></italic> mice received vehicle (left) or <italic>AAV-Cre</italic> (right) injection. Five weeks after the injection. Magenta and green represent <italic>Oxt</italic> and <italic>Cre</italic> in situ stainings, respectively. Blue, DAPI. Scale bar, 50 μm. (<bold>C</bold>) The number of remaining <italic>Oxt</italic>+ neurons in the SO of mice that received <italic>AAV-Cre</italic> injection. **p&lt;0.01, one-way ANOVA with post hoc Tukey’s HSD. N=5 each. (<bold>D</bold>) The body weight of <italic>Oxt<sup>flox/–</sup></italic> mice did not differ between vehicle or <italic>AAV-Cre</italic> (Student’s <italic>t</italic>-test). N=6 each. Data were obtained at 5 weeks after the injection. (<bold>E</bold>) Relationship between the number of remaining <italic>Oxt</italic>+ neurons in the SO and the body weight of <italic>Oxt<sup>flox/–</sup></italic> mice shown in (<bold>D</bold>). Magenta, exponential fit for the data from both Cre and vehicle. (<bold>F</bold>) The time course of daily food intake was not statistically different (Student’s <italic>t</italic>-test with post hoc Bonferroni correction). N=6 each. (<bold>G</bold>) Cumulative food intake during the 5 weeks after the injection. N=6 each.</p><p>Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig2-v1.tif"/></fig><p>Because of the minor role of SO Oxt neurons, we focused on the PVH Oxt neurons in the following experiments.</p></sec><sec id="s2-2"><title>Weight of viscera and blood constituents</title><p>Increased food intake may influence not only body weight, but also the viscera and blood constituents. To examine these points, we collected internal organs and blood samples from non-fasted <italic>Oxt<sup>flox/–</sup></italic> mice that had received either <italic>AAV-Cre</italic> or vehicle injection into the bilateral PVH (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). While the weight of the stomach was unchanged (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), a significant increase was observed in the weight of the liver in <italic>Oxt<sup>flox/–</sup></italic> mice with <italic>AAV-Cre</italic> injection, likely because of the accumulation of fat in the liver (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). We next measured the plasma concentration of glucose, triglyceride, and leptin. No significant differences in glucose levels were found (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In turn, the plasma concentrations of triglyceride and leptin were higher in <italic>Oxt<sup>flox/–</sup></italic> mice that had received <italic>AAV-Cre</italic> injection than in those that had received vehicle injection (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Of note, a prominent increase in plasma leptin was also reported in the late-onset obesity cases of 6-month-old <italic>Oxt</italic> KO mice (<xref ref-type="bibr" rid="bib7">Camerino, 2009</xref>). Our data regarding <italic>Oxt</italic> cKO showed the plasma leptin phenotype in the earlier stage of 13-week-old mice. These results suggest that the cKO of <italic>Oxt</italic> affects the homeostasis of viscera and blood constituents.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Weight of viscera and the blood constituents.</title><p>(<bold>A</bold>) Schematic of the virus injection. <italic>AAV-Cre</italic> or vehicle was injected into the bilateral paraventricular hypothalamic nucleus (PVH) of <italic>Oxt<sup>flox/–</sup></italic> male. Data were obtained at 5 weeks after the injection. (<bold>B</bold>) The weight of the stomach was not statistically different (p&gt;0.5, Student’s <italic>t</italic>-test. N=9 and 10 for vehicle and Cre, respectively). (<bold>C</bold>) The weight of the liver was significantly heavier in <italic>AAV-Cre</italic>-injected mice (***p&lt;0.001, Student’s <italic>t</italic>-test). (<bold>D</bold>) Plasma glucose (left), triglyceride (middle), and leptin (right) measured in the non-fasted <italic>Oxt<sup>flox/–</sup></italic> mice. **p&lt;0.01, ***p&lt;0.001, Student’s <italic>t</italic>-test. N=9 and 8 mice for vehicle and Cre, respectively.</p><p>Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig3-v1.tif"/></fig></sec><sec id="s2-3"><title>Oxt supplementation partially rescues <italic>Oxt</italic> cKO</title><p>If <italic>Oxt</italic> cKO caused increases in body weight and food intake with higher plasma triglyceride and leptin, such effects might be mitigated by the external administration of Oxt. This hypothesis is also supported by the fact that intraperitoneal (ip) or intracerebroventricular injection of Oxt has been shown to reduce both body weight and food intake (<xref ref-type="bibr" rid="bib28">Maejima et al., 2018</xref>). To examine this hypothesis, first, we injected <italic>AAV-Cre</italic> into the bilateral PVH of <italic>Oxt<sup>flox/–</sup></italic> mice, and from the next day of the injection, we conducted ip injection of Oxt (100 μL of 500 μM or 1 mM solution) once every 3 days (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Ip injection of the vehicle was used as control. At 5 weeks after the injection of <italic>AAV-Cre</italic>, Oxt-treated mice showed significantly reduced body weight, even though the number of remaining <italic>Oxt</italic>+ neurons was not significantly different (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>). We found that both daily food intake at 4–5 weeks and total food intake during the 5 weeks after the injection were also significantly reduced (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>). The reduction of body weight and food intake by our Oxt treatment paradigm was somehow specific to <italic>Oxt</italic> cKO mice, given that neither reduction of food intake nor body weight was observed in wild-type males (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref>). No significant improvement in the blood samples was found: both plasma triglyceride and leptin tended to be reduced in Oxt-treated mice, but did not reach the level of statistical significance (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). These results suggest that external administration of Oxt can rescue at least the hyperphagic obesity phenotype of <italic>Oxt</italic> cKO.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Intraperitoneal (ip) injection of oxytocin (Oxt) partially rescues paraventricular hypothalamic nucleus (PVH) <italic>Oxt</italic> conditional knockout (cKO) phenotypes.</title><p>(<bold>A</bold>) Schematic of the experiments. <italic>AAV-Cre</italic> was injected into the bilateral PVH of <italic>Oxt<sup>flox/–</sup></italic> male mice. Data were obtained 5 weeks after the virus injection. Once every 3 days, the mice received ip injection of vehicle, 50.36 μg of Oxt (condition 1) or 100.72 μg of Oxt (condition 2) (see Materials and methods). (<bold>B</bold>) The number of remaining <italic>Oxt+</italic> neurons was not statistically different (p&gt;0.9, one-way ANOVA). Cond, condition. N=5 each (same mice across panels <bold>B–E</bold>). (<bold>C</bold>) Ip injection of Oxt significantly decreased body weight. **p&lt;0.01, one-way ANOVA with post hoc Tukey’s HSD. Cond, condition. (<bold>D</bold>) Time course of daily food intake. Asterisks (*) denote significant differences for vehicle versus condition 1 and vehicle versus condition 2 (p&lt;0.05, Tukey’s HSD), and hashes (#) denote significant differences for vehicle versus condition 1, vehicle versus condition 2, and condition 1 versus condition 2 (p&lt;0.05, Tukey’s HSD). (<bold>E</bold>) Cumulative food intake during the 5 weeks after the virus injection was decreased in the mice that received ip injection of Oxt (*p&lt;0.05, one-way ANOVA with post hoc Tukey’s HSD). Cond, condition. (<bold>F</bold>) Plasma glucose (left), triglyceride (middle), and leptin (right) measured in the non-fasted <italic>Oxt<sup>flox/–</sup></italic> mice. Decreases in triglyceride and leptin on average were found in Oxt-treated mice but did not reach the level of statistical significance (p=0.314 and 0.065 for triglyceride and leptin, respectively, Student’s <italic>t</italic>-test). N=5 each.</p><p>Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Intraperitoneal (Ip) injection of oxytocin (Oxt) does not affect either body weight or food intake in wild-type mice, but reduces the hourly food intake of mice with <italic>Oxt</italic> conditional knockout (cKO) in the paraventricular hypothalamic nucleus (PVH).</title><p>(<bold>A</bold>) Schematic of the experiments. <italic>AAV-Cre</italic> was injected into the bilateral PVH of wild-type male mice. The procedure used for the ip injection of Oxt solution was the same as that in <xref ref-type="fig" rid="fig4">Figure 4</xref>. (<bold>B</bold>) Body weight measured at 5 weeks after the injection was not statistically different (p&gt;0.41, one-way ANOVA). N=8 each. (<bold>C</bold>) Daily food intake measured at 5 weeks after the injection (p&gt;0.068, one-way ANOVA). N=8 each. (<bold>D</bold>) Cumulative food intake during the 5 weeks after the injection was not statistically different (p&gt;0.46, one-way ANOVA). N=8 each. (<bold>E</bold>) Schematic of the experiments. <italic>AAV-Cre</italic> was injected into the bilateral PVH of <italic>Oxt<sup>flox/–</sup></italic> male mice. Data were obtained at 5 weeks after the virus injection. (<bold>F</bold>) Schematic of the timeline of the experiment. Each mouse fasted for 6 hr. Food intake was measured at 1, 3, and 5 hr after the placement of food and ip injection of Oxt or vehicle. (<bold>G</bold>) The number of remaining <italic>Oxt+</italic> neurons in the PVH was not statistically different (p&gt;0.52, one-way ANOVA). Cond, condition. N=6 each (same mice across panels<bold> G</bold> and <bold>H</bold>). (<bold>H</bold>) Cumulative food intake. Asterisks (*) denote significant differences for vehicle versus condition 1 (p&lt;0.05, one-way ANOVA with post hoc Tukey’s HSD) and vehicle versus condition 2 (p&lt;0.01), and hashes (#) denote significant differences for vehicle versus condition 1 (p&lt;0.01) and vehicle versus condition 2 (p&lt;0.01).</p><p>Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig4-figsupp1-v1.tif"/></fig></fig-group><p>In addition to the daily food intake that we have examined so far, previous studies showed that mice ate less within several hours after receiving ip injection of Oxt (<xref ref-type="bibr" rid="bib2">Arletti et al., 1989</xref>; <xref ref-type="bibr" rid="bib26">Maejima et al., 2011</xref>). To examine whether <italic>Oxt<sup>flox/–</sup></italic> mice that receive <italic>AAV-Cre</italic> injection similarly show reduced hourly food intake, we measured food intake after 6 hr of fasting (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E and F</xref>). After fasting, the mice received an ip injection of Oxt, and food was provided again (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>). Cumulative food intake was measured at 1, 3, and 5 hr after the placement of food (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>). Although the number of remaining <italic>Oxt+</italic> neurons was comparable (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>), Oxt-injected mice ate less (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>). Taken together, ip injection of Oxt appears to reduce food intake on the scale of hours to days, thereby preventing the hyperphagic obesity induced by <italic>Oxt</italic> cKO in the PVH.</p></sec><sec id="s2-4"><title><italic>Oxtr</italic>-expressing cells in the ARH mediate appetite suppression</title><p>Having established the importance of Oxt to suppress hyperphagic obesity, we examined the site of action of Oxt signaling that mediates appetite suppression. To this end, we prepared <italic>Oxtr<sup>flox/flox</sup></italic> mice, in which the <italic>Oxtr</italic> gene can be knocked out under Cre expression (<xref ref-type="bibr" rid="bib45">Takayanagi et al., 2005</xref>). Given that PVH Oxt neurons send dense projection to the hypothalamic nuclei (<xref ref-type="bibr" rid="bib53">Yao et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Zhang et al., 2021</xref>), and that OxtR expression is also found in the hypothalamus (<xref ref-type="bibr" rid="bib13">Fenselau et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Mitre et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Newmaster et al., 2020</xref>), we suspected that a fraction of appetite suppression signals is mediated by the other nuclei of the hypothalamus. To test this possibility, we injected <italic>AAV-Cre</italic> (serotype 9) into the bilateral ‘anterior hypothalamus’, mainly aiming at nuclei such as the anteroventral periventricular nucleus, medial preoptic nucleus medial part (MPNm), MPN lateral part, and medial preoptic area (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; see Materials and methods), and the ‘posterior hypothalamus’, containing nuclei such as the dorsomedial nucleus of the hypothalamus, ventromedial hypothalamic nucleus (VMH), lateral hypothalamic area (LHA), and ARH (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). AAV-mediated <italic>Cre</italic> expression roughly covered these nuclei (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). To examine if Cre expression reduced <italic>Oxtr</italic> expression, we visualized <italic>Oxtr</italic> mRNA using the RNAscope assay (see the Materials and methods) (<xref ref-type="bibr" rid="bib39">Sato et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Wang et al., 2012</xref>). As <italic>Oxtr</italic> expression was observed as a dot-like structure (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>), we counted the number of such RNAscope dots in each DAPI+ cell. In a negative control experiment utilizing <italic>Oxtr</italic> KO mice, we often detected one or two RNAscope dots in the DAPI+ cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>). Therefore, we regarded a cell with three or more dots as an <italic>Oxtr</italic>-expressing cell (<italic>Oxtr</italic>+; <xref ref-type="fig" rid="fig5">Figure 5G and H</xref>, and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A–C</xref>). We found that <italic>AAV-Cre</italic> injection successfully reduced the number of <italic>Oxtr</italic>+ cells in most of the targeted nuclei (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>). <italic>Oxtr</italic> cKO in the posterior but not anterior hypothalamus significantly increased body weight (<xref ref-type="fig" rid="fig5">Figure 5I and J</xref>). Similarly, a significant increase in food intake was observed in the mice that had received <italic>AAV-Cre</italic> injection into the posterior hypothalamus (<xref ref-type="fig" rid="fig5">Figure 5K and L</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Oxtr</italic> conditional knockout (cKO) in the posterior hypothalamus induces increases in body weight and food intake.</title><p>(<bold>A, B</bold>) Schematic of the virus injection. <italic>AAV-Cre</italic> or vehicle was injected into the bilateral anterior or posterior hypothalamus (see Materials and methods) of <italic>Oxtr<sup>flox/flox</sup></italic> male mice. (<bold>C, D</bold>) Representative coronal section showing <italic>Cre</italic> mRNA (green). Blue, DAPI. Scale bar, 50 μm. (<bold>E</bold>) A representative coronal section showing anteroventral periventricular nucleus (AVPV) and medial preoptic nucleus medial part (MPNm) from a vehicle-injected mouse. <italic>Oxtr</italic> mRNA was visualized by RNAscope (magenta). Blue, DAPI. Scale bar, 30 μm. (<bold>F</bold>) Projection of a confocal stack in MPNm from a vehicle-injected mouse. Magenta, <italic>Oxtr</italic> mRNA. Blue, DAPI. Scale bar, 5 μm. (<bold>G, H</bold>) Fraction of DAPI+ cells expressing <italic>Oxtr</italic>. Cells showing three or more RNAscope dots were defined as <italic>Oxtr</italic>+ (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Veh, vehicle. N=5 each. **p&lt;0.01, ***p&lt;0.001, Student’s <italic>t</italic>-test with Bonferroni correction. Decreases in the MPN lateral part (MPNl), medial preoptic area (MPO), and arcuate hypothalamic nucleus (ARH) on average were found in <italic>AAV-Cre</italic>-injected mice but did not reach the level of statistical significance in Student’s <italic>t</italic>-test with Bonferroni correction (p=0.045, 0.289, and 0.012, respectively). (<bold>I, J</bold>) Body weight measured at 5 weeks after the injection. **p&lt;0.01, Student’s <italic>t</italic>-test. Anterior hypothalamus, N=5 and 6 for vehicle and Cre, respectively, and posterior hypothalamus, N=5 and 6 for vehicle and Cre, respectively. (<bold>K, L</bold>) Daily food intake measured at 5 weeks after the injection. ***p&lt;0.001, Student’s <italic>t</italic>-test. Anterior hypothalamus, N=5 and 6 for vehicle and Cre, respectively, and posterior hypothalamus, N=5 and 6 for vehicle and Cre, respectively. Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Distribution of <italic>oxytocin receptor</italic> (<italic>Oxtr)</italic>+ RNAscope dots.</title><p>(<bold>A, B</bold>) Fraction of the number of Oxtr+ RNAscope dots in each DAPI+ cell in the nuclei in the anterior hypothalamus (<bold>A</bold>) or posterior hypothalamus (<bold>B</bold>). Black and green represent vehicle and <italic>AAV-Cre</italic> injected into the anterior hypothalamus (<bold>A</bold>) or posterior hypothalamus (<bold>B</bold>) in <italic>Oxtr<sup>flox/flox</sup></italic> mice, respectively. Data from the same mice shown in <xref ref-type="fig" rid="fig5">Figure 5G and H</xref>. Magenta represents <italic>Oxtr</italic> knockout (KO) mice (N=3 and 5 for anterior and posterior, respectively). Dotted lines indicate three <italic>Oxtr</italic>+ dots in each DAPI+ cell.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Testing the stringency in the definition of <italic>oxytocin receptor</italic> (<italic>Oxtr)</italic>+ cell by different numbers of RNAscope dots.</title><p>(<bold>A</bold>) Calculation of the fraction of <italic>Oxtr+</italic> cells as defined in this equation: we counted the number of RNAscope dots in each DAPI+ cell and defined a cell with M or more dots as an <italic>Oxtr</italic>-expressing cell in this figure. (<bold>B, C</bold>) Because we observed RNAscope dots in the <italic>Oxtr</italic> knockout (KO) mice in which no <italic>Oxtr</italic> mRNA should be expressed, we evaluated the fraction of pseudo-positive detection with varying M values. Relationship between M and the fraction of <italic>Oxtr</italic>+ cells in the anterior hypothalamus (<bold>B</bold>) and posterior hypothalamus (<bold>C</bold>). Given that the pseudo-positive ratio on average was less than 5% (dotted line) in M≥3, we defined a DAPI+ cell with three or more dots as an <italic>Oxtr+</italic> cell in <xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>. N=3 and 5 mice for anterior and posterior, respectively.</p><p>Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig5-figsupp2-v1.tif"/></fig></fig-group><p>We next aimed to pinpoint a specific nucleus in the posterior hypothalamus that could suppress hyperphagic obesity. To this end, we injected <italic>AAV-Cre</italic> (serotype 2) into the ARH or LHA (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). This serotype of AAV-driven <italic>Cre</italic> expression was spatially localized (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>) compared with the AAV serotype 9 used in <xref ref-type="fig" rid="fig5">Figure 5</xref>. AAV-driven <italic>Cre</italic> expression reduced <italic>Oxtr</italic> expression in <italic>Oxtr<sup>flox/flox</sup></italic> mice (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>). Body weight, daily food intake, and cumulative food intake were significantly greater in the mice that received <italic>AAV-Cre</italic> injection into the ARH, whereas no significant difference was found in the mice that expressed <italic>Cre</italic> in the LHA (<xref ref-type="fig" rid="fig6">Figure 6G-L</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>Oxytocin receptor (Oxtr)</italic> expression in the arcuate hypothalamic nucleus (ARH) suppresses body weight and food intake.</title><p>(<bold>A, B</bold>) Schematic of the virus injection. <italic>AAV-Cre</italic> or vehicle was injected into the bilateral ARH or lateral hypothalamic area (LHA) of <italic>Oxtr<sup>flox/flox</sup></italic> male mice. (<bold>C, D</bold>) Representative coronal section showing <italic>Cre</italic> mRNA (green). Blue, DAPI. Scale bar, 50 μm. (<bold>E, F</bold>) Left, representative coronal section showing the ARH or LHA from a vehicle-injected mouse. <italic>Oxtr</italic> mRNA was visualized by RNAscope (magenta). Blue, DAPI. Scale bar, 5 μm. Right, fraction of DAPI+ cells expressing <italic>Oxtr</italic> in the ARH (<bold>E</bold>) or LHA (<bold>F</bold>) and ventromedial hypothalamic nucleus (VMH), a neighboring nucleus of the ARH and LHA. Cells showing three or more RNAscope dots were defined as <italic>Oxtr</italic>+. N=5 each. ***p&lt;0.001, Student’s <italic>t</italic>-test with Bonferroni correction. (<bold>G, H</bold>) Body weight measured at 5 weeks after the injection. *p&lt;0.05, Student’s <italic>t</italic>-test. N=5 each. (<bold>I, J</bold>) Daily food intake measured at 5 weeks after the injection. **p&lt;0.01, Student’s <italic>t</italic>-test. N=5 each. (<bold>K, L</bold>) Cumulative food intake during the 5 weeks after the injection. *p&lt;0.05, Student’s <italic>t</italic>-test. N=5 each.</p><p>Error bars, SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75718-fig6-v1.tif"/></fig><p>Taken together, these results indicate that a fraction of the appetite suppression signals from Oxt neurons is mediated by <italic>Oxtr</italic>-expressing cells in the posterior hypothalamus, especially those in the ARH.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title><italic>Oxt</italic> cKO increased body weight and food intake</title><p>In this study, we performed cKO of the <italic>Oxt</italic> gene by injecting <italic>AAV-Cre</italic>, which enabled region-specific KO of <italic>Oxt</italic>. By this advantage, we showed that Oxt produced by PVH Oxt neurons contributes to the regulation of body weight and food intake, whereas that by SO Oxt neurons does not (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref>). These data extend the previous results that mechanical disruption of PVH in rats increased both body weight and food intake (<xref ref-type="bibr" rid="bib40">Shor-Posner et al., 1985</xref>; <xref ref-type="bibr" rid="bib41">Sims and Lorden, 1986</xref>). In contrast to the <italic>Oxt</italic> cKO phenotype (<xref ref-type="fig" rid="fig1">Figure 1H and I</xref>), whole-body <italic>Oxt</italic> KO mice showed a normal amount of food intake (<xref ref-type="bibr" rid="bib7">Camerino, 2009</xref>), suggesting compensational mechanisms. For example, when a certain gene is knocked out, expression of the related gene(s) is enhanced to compensate for some of the KO phenotypes functionally (<xref ref-type="bibr" rid="bib12">El-Brolosy et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Ma et al., 2019</xref>). Transcriptomic analysis between <italic>Oxt</italic> KO and wild type may reveal a more complete picture of gene expression that can explain the compensational mechanisms in <italic>Oxt</italic> KO mice.</p><p>The phenotypic discrepancy between our data and diphtheria toxin-induced ablation of Oxt cells (<xref ref-type="bibr" rid="bib52">Wu et al., 2012b</xref>) might be due to the loss of Oxt cells outside the PVH (maybe even outside the brain; <xref ref-type="bibr" rid="bib36">Paiva et al., 2021</xref>) that somehow elicited appetite suppression, and therefore counterbalanced the overeating phenotype caused by the loss of <italic>Oxt</italic> in the PVH. Alternatively, neuropeptides or neurotransmitters other than Oxt expressed in the PVH Oxt neurons might have conveyed appetite-stimulating signals, which remained intact in our <italic>Oxt</italic>-selective cKO model, but were disrupted in the cell-based ablation, resulting in only the overeating phenotype to appear in our case. Regardless of the scenario, our data establish the necessity of Oxt in the PVH to suppress overeating and suggest the presence of a hormone-based output pathway of PVH appetite regulation signals, in addition to the well-established neural pathways mediated by MC4R neurons (<xref ref-type="bibr" rid="bib14">Garfield et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Stachniak et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Sutton et al., 2016</xref>).</p></sec><sec id="s3-2"><title>Downstream of Oxt neurons that mediate appetite suppression signals</title><p>After eating a sufficient amount of food, animals stop eating owing to the appetite suppression signals mediated in the brain. Several brain regions and cell types, such as Pomc-expressing neurons in the ARH (<xref ref-type="bibr" rid="bib32">Ollmann et al., 1997</xref>; <xref ref-type="bibr" rid="bib43">Sternson and Eiselt, 2017</xref>; <xref ref-type="bibr" rid="bib44">Sutton et al., 2016</xref>), glutamatergic <italic>Oxtr</italic>-expressing neurons in the ARH (<xref ref-type="bibr" rid="bib13">Fenselau et al., 2017</xref>), and calcitonin gene-related peptide expressing neurons in the parabrachial nucleus (<xref ref-type="bibr" rid="bib8">Carter et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Wu et al., 2012a</xref>), have been identified in this process. Our data showed that PVH Oxt neurons mediated appetite suppression signals. Previous studies have shown that both oxytocinergic neurites and <italic>Oxtr</italic>-expressing neurons can be found in various brain and spinal cord regions (<xref ref-type="bibr" rid="bib18">Jurek and Neumann, 2018</xref>; <xref ref-type="bibr" rid="bib21">Lefevre et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Newmaster et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Oti et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Zhang et al., 2021</xref>). In the present study, by <italic>AAV-Cre</italic>-mediated cKO, we found that <italic>Oxtr</italic> expressed by neurons in the posterior hypothalamic regions, especially those in the ARH, mediates appetite suppression signals (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). Our data are, therefore, generally consistent with the view that <italic>Oxtr</italic>-expressing neurons in the ARH evoke satiety signaling (<xref ref-type="bibr" rid="bib13">Fenselau et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Maejima et al., 2014</xref>); however, we do not exclude the possibility that OxtR in the other parts of the posterior hypothalamus, such as the VMH (<xref ref-type="bibr" rid="bib23">Leng et al., 2008</xref>; <xref ref-type="bibr" rid="bib48">Viskaitis et al., 2017</xref>) and medulla (<xref ref-type="bibr" rid="bib34">Ong et al., 2017</xref>), also contributes to appetite suppression. Collectively, we suggest that one of the output pathways of the PVH for body weight homeostasis is mediated by Oxt signaling-based modulation of other hypothalamic appetite regulation systems.</p><p>We also showed that ip administration of Oxt can mitigate the overeating phenotype caused by the PVH <italic>Oxt</italic> cKO model (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Together with the importance of OxtR signaling in the ARH, one possibility is that the primary hypothalamic neurons that are located outside the blood-brain barrier (<xref ref-type="bibr" rid="bib54">Yulyaningsih et al., 2017</xref>) directly receive ip-injected Oxt and transmit appetite suppression signals. Alternatively, OxtR-expressing neurons in the peripheral nervous system, such as those in the vagal sensory neurons transmitting intentional appetite suppression signals (<xref ref-type="bibr" rid="bib4">Bai et al., 2019</xref>), may indirectly modify feeding. Future studies should further dissect the responsible cell types and physiological functions of OxtR signaling in the ARH. Recent advances in the real-time imaging of OxtR activities, for example, with a circularly permuted green fluorescent protein binding to OxtR (<xref ref-type="bibr" rid="bib16">Ino et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Qian et al., 2022</xref>), would be useful for delineating the circuit mechanism and spatiotemporal dynamics of the Oxt-mediated suppression of hyperphagic obesity, such as by pinpointing the site of Oxt release.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (mouse, male)</td><td align="left" valign="bottom"><italic>Oxt</italic> KO</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib15">Inada et al., 2022</xref></td><td align="left" valign="bottom">#CDB0204E</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (mouse, male)</td><td align="left" valign="bottom"><italic>Oxt</italic> cKO (floxed)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib15">Inada et al., 2022</xref></td><td align="left" valign="bottom">#CDB0116E</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (mouse, male)</td><td align="left" valign="bottom"><italic>Oxtr<sup>flox/flox</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib45">Takayanagi et al., 2005</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AAV9-<italic>hSyn-Cre</italic></td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_105555-AAV9">Addgene_105555-AAV9</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AAV2-<italic>CMV-Cre-GFP</italic></td><td align="left" valign="bottom">University of North Carolina viral core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.med.unc.edu/genetherapy/vectorcore/in-stock-aav-vectors/reporter-vectors/">https://www.med.unc.edu/genetherapy/vectorcore/in-</ext-link><break/><ext-link ext-link-type="uri" xlink:href="https://www.med.unc.edu/genetherapy/vectorcore/in-stock-aav-vectors/reporter-vectors/">stock-aav-vectors/reporter-vectors/</ext-link></td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAscope Multiplex Fluorescent Reagent Kit</td><td align="left" valign="bottom">Advance Cell Diagnostics</td><td align="char" char="." valign="bottom">323110</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAscope Mm-OXTR</td><td align="left" valign="bottom">Advance Cell Diagnostics</td><td align="char" char="." valign="bottom">412171</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Igor Pro</td><td align="left" valign="bottom">Wavemetrics</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000325">SCR_000325</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>All experiments were conducted with virgin male mice. Animals were housed under a 12 hr light/12 hr dark cycle with ad libitum access to water and standard mouse pellets (MFG; Oriental Yeast, Shiga, Japan; 3.57 kcal/g). Wild-type C57BL/6J mice were purchased from Japan SLC (Hamamatsu, Japan). <italic>Oxt</italic> KO (Accession No. CDB0204E) and cKO (Accession No. CDB0116E) lines (listed at <ext-link ext-link-type="uri" xlink:href="http://www2.clst.riken.jp/arg/mutant%20mice%20list.html">http://www2.clst.riken.jp/arg/mutant%20mice%20list.html</ext-link>) were generated and validated previously (<xref ref-type="bibr" rid="bib15">Inada et al., 2022</xref>). The <italic>Oxtr<sup>flox/flox</sup></italic> mouse line has been described (<xref ref-type="bibr" rid="bib45">Takayanagi et al., 2005</xref>). <italic>Oxtr</italic> KO mice were generated by injecting <italic>Cre</italic> mRNA into the <italic>Oxtr<sup>flox/flox</sup></italic> zygotes. We used only the mice that had the deletion allele without the <italic>flox</italic> allele by genotype PCR in the analysis. We confirmed the result of <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref> in a small number of <italic>Oxtr</italic> KO mice that had been generated by conventional crossing from Oxtr <italic>flox</italic> mice. All animal procedures followed the animal care guidelines approved by the Institutional Animal Care and Use Committee of the RIKEN Kobe branch.</p><p>We chose the <italic>Oxt flox/null</italic> model to increase the efficiency of cKO (<xref ref-type="fig" rid="fig1">Figures 1</xref>—<xref ref-type="fig" rid="fig4">4</xref>). If we had used the <italic>Oxt flox/flox</italic> mice for cKO, because of high <italic>Oxt</italic> gene expression levels, a small fraction of the <italic>flox</italic> alleles that do not experience recombination would easily mask the phenotypes. Because <italic>flox/null</italic> alone (without Cre) has no phenotype (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), we could justify the use of the <italic>flox/null</italic> model. Regarding <italic>Oxtr</italic> cKO (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>), we chose the <italic>flox/flox</italic> model because the haploinsufficiency gene effect of <italic>Oxtr</italic> has been reported, at least in the context of social behaviors (<xref ref-type="bibr" rid="bib38">Sala et al., 2013</xref>).</p></sec><sec id="s4-2"><title>Stereotactic viral injections</title><p>We obtained the AAV serotype 9 <italic>hSyn-Cre</italic> from Addgene (#105555; titer: 2.3×10<sup>13</sup> genome particles/mL) and the AAV serotype 2 <italic>CMV-Cre-GFP</italic> from the University of North Carolina viral core (7.1×10<sup>12</sup> genome particles/mL). To target the AAV or saline (vehicle) into a specific brain region, stereotactic coordinates were defined for each brain region based on the Allen Mouse Brain Atlas (<xref ref-type="bibr" rid="bib22">Lein et al., 2007</xref>). Mice were anesthetized with 65 mg/kg ketamine (Daiichi Sankyo, Tokyo, Japan) and 13 mg/kg xylazine (X1251; Sigma-Aldrich) via ip injection and head-fixed to stereotactic equipment (Narishige, Tokyo, Japan). The following coordinates were used (in mm from the bregma for anteroposterior [AP], mediolateral [ML], and dorsoventral [DV]): PVH, AP –0.8, ML 0.2, DV 4.5; SO, AP –0.7, ML 1.2, DV 5.5; LHA, AP –2.0, ML 1.2, DV 5.2; ARH, AP –2.0, ML 0.2, DV 5.8. We defined the anterior and posterior hypothalamus by the following coordinates: anterior, AP +0.2, ML 0.2, DV 5.2; posterior, AP –1.7, ML 1.0, DV 5.2. The injected volume of AAV was 200 nL at a speed of 50 nL/min. After viral injection, the animal was returned to the home cage. In <xref ref-type="fig" rid="fig4">Figure 4</xref>, 100 μL of Oxt (1910, Tocris) dissolved in saline (vehicle) at 500 μM or 1 mM was ip-injected once every 3 days from the next day of <italic>AAV-Cre</italic> injection.</p></sec><sec id="s4-3"><title>Measurement of food intake</title><p>Food intake was measured by placing pre-weighted food pellets on the plate of a cage and reweighing them. In all the experiments, except those in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E–H</xref>, daily food intake was measured as follows: 200 g of food pellets were placed and food intake was measured once a week (weekly food intake). Daily food intake was calculated by dividing the weekly food intake by 7 (days) and reported with significance digits of 0.1 g. In <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E–H</xref>, after 6 hr of fasting, 100 μL of Oxt dissolved in saline (vehicle) at 500 μM or 1 mM was ip-injected. Then, 80.0 g of food was placed and food intake was measured in units of 0.1 g after 1, 3, and 5 hr.</p></sec><sec id="s4-4"><title>Fluorescent ISH</title><p>Fluorescent ISH was performed as previously described (<xref ref-type="bibr" rid="bib15">Inada et al., 2022</xref>; <xref ref-type="bibr" rid="bib17">Ishii et al., 2017</xref>). In brief, mice were anesthetized with sodium pentobarbital and perfused with PBS followed by 4% PFA in PBS. The brain was post-fixed with 4% PFA overnight. Twenty µm coronal brain sections were made using a cryostat (Leica). The following primer sets were used in this study: <italic>Cre</italic> forward, <named-content content-type="sequence">CCAAGAAGAAGAGGAAGGTGTC</named-content>; <italic>Cre</italic> reverse, <named-content content-type="sequence">ATCCCCAGAAATGCCAGATTAC</named-content>; <italic>Oxt</italic> forward, <named-content content-type="sequence">AAGGTCGGTCTGGGCCGGAGA</named-content>; and <italic>Oxt</italic> reverse, <named-content content-type="sequence">TAAGCCAAGCAGGCAGCAAGC</named-content>. Fluoromount (K024; Diagnostic BioSystems) was used as a mounting medium. Brain images were acquired using an Olympus BX53 microscope equipped with a ×10 (NA 0.4) objective lens. Cells were counted manually using the ImageJ Cell Counter plugin. In <xref ref-type="fig" rid="fig1">Figures 1C</xref> and <xref ref-type="fig" rid="fig2">2C</xref>, cells were counted by an experimenter who was blind to the experimental conditions.</p></sec><sec id="s4-5"><title>RNAscope assay</title><p><italic>Oxtr</italic> mRNA was visualized by the RNAscope Multiplex Fluorescent Reagent Kit (323110; Advance Cell Diagnostics [ACD]) according to the manufacturer’s instructions. In brief, 20 µm coronal brain sections were made using a cryostat (Leica). A probe against <italic>Oxtr</italic> (Mm-OXTR, 412171, ACD) was hybridized in a HybEZ Oven (ACD) for 2 hr at 40°C. Then, the sections were treated with TSA-plus Cyanine 3 (NEL744001KT; Akoya Biosciences; 1:1500). Fluoromount (K024; Diagnostic BioSystems) was used as a mounting medium. Images subjected to the analysis were acquired using an Olympus BX53 microscope equipped with a ×10 (NA 0.40) or ×20 (NA 0.75) objective lens, as shown in <xref ref-type="fig" rid="fig5">Figures 5E</xref>, <xref ref-type="fig" rid="fig6">6E and F</xref>. <xref ref-type="fig" rid="fig5">Figure 5F</xref> was obtained with a confocal microscope (LSM780, Zeiss) equipped with a ×63 oil-immersion objective lens (NA 1.40). RNAscope dots were counted manually using the ImageJ Cell Counter plugin.</p></sec><sec id="s4-6"><title>Measurements of the weight of livers and stomachs</title><p>Mice were anesthetized with sodium pentobarbital. Livers and stomachs were obtained without perfusion and their weight was immediately measured. Before measurement, the stomach was gently pressed to eject the remaining contents.</p></sec><sec id="s4-7"><title>Plasma measurements</title><p>Mice were fed ad libitum before blood sampling. Mice were anesthetized with isoflurane and blood was collected from the heart. EDTA was used to prevent blood coagulation. Plasma concentrations of glucose, triglycerides, and leptin were measured by the enzymatic method, HK-G6PDH, and ELISA, respectively, through a service provided by Oriental Yeast (Shiga, Japan).</p></sec><sec id="s4-8"><title>Data analysis</title><p>All mean values are reported as the mean ± SEM. The statistical details of each experiment, including the statistical tests used, the exact value of n, and what n represents, are shown in each figure legend. The p-values are shown in each figure legend or panel; nonsignificant values are not noted. In <xref ref-type="fig" rid="fig1">Figures 1G</xref> and <xref ref-type="fig" rid="fig2">2E</xref>, exponential fit was calculated by Igor (WaveMetrics).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis</p></fn><fn fn-type="con" id="con3"><p>Resources</p></fn><fn fn-type="con" id="con4"><p>Resources</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal procedures followed animal care guidelines approved by the Institutional Animal Care and Use Committee of the RIKEN Kobe branch (#A2017-15-12).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-75718-transrepform1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and the figure supplement.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We wish to thank Mitsue Hagihara for the extensive technical support, the Laboratory for Comprehensive Bioimaging for the microscopy services, and the members of the Miyamichi lab for their comments on an earlier version of this manuscript. This work was supported by the RIKEN Special Postdoctoral Researchers Program, a grant from the Kao Foundation for Arts and Sciences, and JSPS KAKENHI (19J00403 and 19K16303) to KI, and the JST CREST program (JPMJCR2021) and JSPS KAKENHI (20K20589) to KM.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andermann</surname><given-names>ML</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Toward a wiring diagram understanding of appetite control</article-title><source>Neuron</source><volume>95</volume><fpage>757</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.014</pub-id><pub-id pub-id-type="pmid">28817798</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arletti</surname><given-names>R</given-names></name><name><surname>Benelli</surname><given-names>A</given-names></name><name><surname>Bertolini</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Influence of oxytocin on feeding behavior in the rat</article-title><source>Peptides</source><volume>10</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/0196-9781(89)90082-x</pub-id><pub-id pub-id-type="pmid">2748428</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atasoy</surname><given-names>D</given-names></name><name><surname>Betley</surname><given-names>JN</given-names></name><name><surname>Su</surname><given-names>HH</given-names></name><name><surname>Sternson</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Deconstruction of a neural circuit for hunger</article-title><source>Nature</source><volume>488</volume><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1038/nature11270</pub-id><pub-id pub-id-type="pmid">22801496</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Mesgarzadeh</surname><given-names>S</given-names></name><name><surname>Ramesh</surname><given-names>KS</given-names></name><name><surname>Huey</surname><given-names>EL</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gray</surname><given-names>LA</given-names></name><name><surname>Aitken</surname><given-names>TJ</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Beutler</surname><given-names>LR</given-names></name><name><surname>Ahn</surname><given-names>JS</given-names></name><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name><name><surname>Knight</surname><given-names>ZA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic identification of vagal sensory neurons that control feeding</article-title><source>Cell</source><volume>179</volume><fpage>1129</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.10.031</pub-id><pub-id pub-id-type="pmid">31730854</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balthasar</surname><given-names>N</given-names></name><name><surname>Dalgaard</surname><given-names>LT</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Funahashi</surname><given-names>H</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Ferreira</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>V</given-names></name><name><surname>McGovern</surname><given-names>RA</given-names></name><name><surname>Kenny</surname><given-names>CD</given-names></name><name><surname>Christiansen</surname><given-names>LM</given-names></name><name><surname>Edelstein</surname><given-names>E</given-names></name><name><surname>Choi</surname><given-names>B</given-names></name><name><surname>Boss</surname><given-names>O</given-names></name><name><surname>Aschkenasi</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Mountjoy</surname><given-names>K</given-names></name><name><surname>Kishi</surname><given-names>T</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Divergence of melanocortin pathways in the control of food intake and energy expenditure</article-title><source>Cell</source><volume>123</volume><fpage>493</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.08.035</pub-id><pub-id pub-id-type="pmid">16269339</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blevins</surname><given-names>JE</given-names></name><name><surname>Schwartz</surname><given-names>MW</given-names></name><name><surname>Baskin</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size</article-title><source>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</source><volume>287</volume><fpage>R87</fpage><lpage>R96</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00604.2003</pub-id><pub-id pub-id-type="pmid">15044184</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camerino</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Low sympathetic tone and obese phenotype in oxytocin-deficient mice</article-title><source>Obesity</source><volume>17</volume><fpage>980</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1038/oby.2009.12</pub-id><pub-id pub-id-type="pmid">19247273</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>ME</given-names></name><name><surname>Soden</surname><given-names>ME</given-names></name><name><surname>Zweifel</surname><given-names>LS</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetic identification of a neural circuit that suppresses appetite</article-title><source>Nature</source><volume>503</volume><fpage>111</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1038/nature12596</pub-id><pub-id pub-id-type="pmid">24121436</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Çatli</surname><given-names>G</given-names></name><name><surname>Acar</surname><given-names>S</given-names></name><name><surname>Cingöz</surname><given-names>G</given-names></name><name><surname>Rasulova</surname><given-names>K</given-names></name><name><surname>Yarim</surname><given-names>AK</given-names></name><name><surname>Uzun</surname><given-names>H</given-names></name><name><surname>Küme</surname><given-names>T</given-names></name><name><surname>Kızıldağ</surname><given-names>S</given-names></name><name><surname>Dündar</surname><given-names>BN</given-names></name><name><surname>Abacı</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Oxytocin receptor gene polymorphism and low serum oxytocin level are associated with hyperphagia and obesity in adolescents</article-title><source>International Journal of Obesity</source><volume>45</volume><fpage>2064</fpage><lpage>2073</lpage><pub-id pub-id-type="doi">10.1038/s41366-021-00876-5</pub-id><pub-id pub-id-type="pmid">34091593</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Sparks</surname><given-names>R</given-names></name><name><surname>Clay</surname><given-names>M</given-names></name><name><surname>Dallman</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Rats with hypothalamic obesity are insensitive to central leptin injections</article-title><source>Endocrinology</source><volume>140</volume><fpage>4426</fpage><lpage>4433</lpage><pub-id pub-id-type="doi">10.1210/endo.140.10.7064</pub-id><pub-id pub-id-type="pmid">10499495</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Patte</surname><given-names>K</given-names></name><name><surname>Zai</surname><given-names>C</given-names></name><name><surname>Kennedy</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Polymorphisms of the oxytocin receptor gene and overeating: the intermediary role of endophenotypic risk factors</article-title><source>Nutrition &amp; Diabetes</source><volume>7</volume><elocation-id>e279</elocation-id><pub-id pub-id-type="doi">10.1038/nutd.2017.24</pub-id><pub-id pub-id-type="pmid">28530679</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Brolosy</surname><given-names>MA</given-names></name><name><surname>Kontarakis</surname><given-names>Z</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Kuenne</surname><given-names>C</given-names></name><name><surname>Günther</surname><given-names>S</given-names></name><name><surname>Fukuda</surname><given-names>N</given-names></name><name><surname>Kikhi</surname><given-names>K</given-names></name><name><surname>Boezio</surname><given-names>GLM</given-names></name><name><surname>Takacs</surname><given-names>CM</given-names></name><name><surname>Lai</surname><given-names>S-L</given-names></name><name><surname>Fukuda</surname><given-names>R</given-names></name><name><surname>Gerri</surname><given-names>C</given-names></name><name><surname>Giraldez</surname><given-names>AJ</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic compensation triggered by mutant mRNA degradation</article-title><source>Nature</source><volume>568</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1064-z</pub-id><pub-id pub-id-type="pmid">30944477</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenselau</surname><given-names>H</given-names></name><name><surname>Campbell</surname><given-names>JN</given-names></name><name><surname>Verstegen</surname><given-names>AMJ</given-names></name><name><surname>Madara</surname><given-names>JC</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Shah</surname><given-names>BP</given-names></name><name><surname>Resch</surname><given-names>JM</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Mandelblat-Cerf</surname><given-names>Y</given-names></name><name><surname>Livneh</surname><given-names>Y</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>42</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/nn.4442</pub-id><pub-id pub-id-type="pmid">27869800</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garfield</surname><given-names>AS</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Madara</surname><given-names>JC</given-names></name><name><surname>Shah</surname><given-names>BP</given-names></name><name><surname>Webber</surname><given-names>E</given-names></name><name><surname>Steger</surname><given-names>JS</given-names></name><name><surname>Campbell</surname><given-names>JN</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Olson</surname><given-names>DP</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name><name><surname>Tannous</surname><given-names>BA</given-names></name><name><surname>Krashes</surname><given-names>MJ</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A neural basis for melanocortin-4 receptor-regulated appetite</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>863</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1038/nn.4011</pub-id><pub-id pub-id-type="pmid">25915476</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inada</surname><given-names>K</given-names></name><name><surname>Hagihara</surname><given-names>M</given-names></name><name><surname>Tsujimoto</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Konno</surname><given-names>A</given-names></name><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Kiyonari</surname><given-names>H</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Plasticity of neural connections underlying oxytocin-mediated parental behaviors of male mice</article-title><source>Neuron</source><volume>110</volume><fpage>2009</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2022.03.033</pub-id><pub-id pub-id-type="pmid">35443152</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ino</surname><given-names>D</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Hibino</surname><given-names>H</given-names></name><name><surname>Nishiyama</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A fluorescent sensor for real-time measurement of extracellular oxytocin dynamics in the brain</article-title><source>Nature Methods</source><volume>19</volume><fpage>1286</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1038/s41592-022-01597-x</pub-id><pub-id pub-id-type="pmid">36138174</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>KK</given-names></name><name><surname>Osakada</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Miyasaka</surname><given-names>N</given-names></name><name><surname>Yoshihara</surname><given-names>Y</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Touhara</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A labeled-line neural circuit for pheromone-mediated sexual behaviors in mice</article-title><source>Neuron</source><volume>95</volume><fpage>123</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.05.038</pub-id><pub-id pub-id-type="pmid">28648498</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The oxytocin receptor: from intracellular signaling to behavior</article-title><source>Physiological Reviews</source><volume>98</volume><fpage>1805</fpage><lpage>1908</lpage><pub-id pub-id-type="doi">10.1152/physrev.00031.2017</pub-id><pub-id pub-id-type="pmid">29897293</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krashes</surname><given-names>MJ</given-names></name><name><surname>Shah</surname><given-names>BP</given-names></name><name><surname>Madara</surname><given-names>JC</given-names></name><name><surname>Olson</surname><given-names>DP</given-names></name><name><surname>Strochlic</surname><given-names>DE</given-names></name><name><surname>Garfield</surname><given-names>AS</given-names></name><name><surname>Vong</surname><given-names>L</given-names></name><name><surname>Pei</surname><given-names>H</given-names></name><name><surname>Watabe-Uchida</surname><given-names>M</given-names></name><name><surname>Uchida</surname><given-names>N</given-names></name><name><surname>Liberles</surname><given-names>SD</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An excitatory paraventricular nucleus to AGRP neuron circuit that drives hunger</article-title><source>Nature</source><volume>507</volume><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1038/nature12956</pub-id><pub-id pub-id-type="pmid">24487620</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>EA</given-names></name><name><surname>Marengi</surname><given-names>DA</given-names></name><name><surname>DeSanti</surname><given-names>RL</given-names></name><name><surname>Holmes</surname><given-names>TM</given-names></name><name><surname>Schoenfeld</surname><given-names>DA</given-names></name><name><surname>Tolley</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Oxytocin reduces caloric intake in men</article-title><source>Obesity</source><volume>23</volume><fpage>950</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1002/oby.21069</pub-id><pub-id pub-id-type="pmid">25865294</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefevre</surname><given-names>A</given-names></name><name><surname>Benusiglio</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Krabichler</surname><given-names>Q</given-names></name><name><surname>Charlet</surname><given-names>A</given-names></name><name><surname>Grinevich</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Oxytocinergic feedback circuitries: an anatomical basis for neuromodulation of social behaviors</article-title><source>Frontiers in Neural Circuits</source><volume>15</volume><elocation-id>688234</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2021.688234</pub-id><pub-id pub-id-type="pmid">34194303</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Ao</surname><given-names>N</given-names></name><name><surname>Ayres</surname><given-names>M</given-names></name><name><surname>Bensinger</surname><given-names>A</given-names></name><name><surname>Bernard</surname><given-names>A</given-names></name><name><surname>Boe</surname><given-names>AF</given-names></name><name><surname>Boguski</surname><given-names>MS</given-names></name><name><surname>Brockway</surname><given-names>KS</given-names></name><name><surname>Byrnes</surname><given-names>EJ</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>T-M</given-names></name><name><surname>Chin</surname><given-names>MC</given-names></name><name><surname>Chong</surname><given-names>J</given-names></name><name><surname>Crook</surname><given-names>BE</given-names></name><name><surname>Czaplinska</surname><given-names>A</given-names></name><name><surname>Dang</surname><given-names>CN</given-names></name><name><surname>Datta</surname><given-names>S</given-names></name><name><surname>Dee</surname><given-names>NR</given-names></name><name><surname>Desaki</surname><given-names>AL</given-names></name><name><surname>Desta</surname><given-names>T</given-names></name><name><surname>Diep</surname><given-names>E</given-names></name><name><surname>Dolbeare</surname><given-names>TA</given-names></name><name><surname>Donelan</surname><given-names>MJ</given-names></name><name><surname>Dong</surname><given-names>H-W</given-names></name><name><surname>Dougherty</surname><given-names>JG</given-names></name><name><surname>Duncan</surname><given-names>BJ</given-names></name><name><surname>Ebbert</surname><given-names>AJ</given-names></name><name><surname>Eichele</surname><given-names>G</given-names></name><name><surname>Estin</surname><given-names>LK</given-names></name><name><surname>Faber</surname><given-names>C</given-names></name><name><surname>Facer</surname><given-names>BA</given-names></name><name><surname>Fields</surname><given-names>R</given-names></name><name><surname>Fischer</surname><given-names>SR</given-names></name><name><surname>Fliss</surname><given-names>TP</given-names></name><name><surname>Frensley</surname><given-names>C</given-names></name><name><surname>Gates</surname><given-names>SN</given-names></name><name><surname>Glattfelder</surname><given-names>KJ</given-names></name><name><surname>Halverson</surname><given-names>KR</given-names></name><name><surname>Hart</surname><given-names>MR</given-names></name><name><surname>Hohmann</surname><given-names>JG</given-names></name><name><surname>Howell</surname><given-names>MP</given-names></name><name><surname>Jeung</surname><given-names>DP</given-names></name><name><surname>Johnson</surname><given-names>RA</given-names></name><name><surname>Karr</surname><given-names>PT</given-names></name><name><surname>Kawal</surname><given-names>R</given-names></name><name><surname>Kidney</surname><given-names>JM</given-names></name><name><surname>Knapik</surname><given-names>RH</given-names></name><name><surname>Kuan</surname><given-names>CL</given-names></name><name><surname>Lake</surname><given-names>JH</given-names></name><name><surname>Laramee</surname><given-names>AR</given-names></name><name><surname>Larsen</surname><given-names>KD</given-names></name><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Lemon</surname><given-names>TA</given-names></name><name><surname>Liang</surname><given-names>AJ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Luong</surname><given-names>LT</given-names></name><name><surname>Michaels</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>JJ</given-names></name><name><surname>Morgan</surname><given-names>RJ</given-names></name><name><surname>Mortrud</surname><given-names>MT</given-names></name><name><surname>Mosqueda</surname><given-names>NF</given-names></name><name><surname>Ng</surname><given-names>LL</given-names></name><name><surname>Ng</surname><given-names>R</given-names></name><name><surname>Orta</surname><given-names>GJ</given-names></name><name><surname>Overly</surname><given-names>CC</given-names></name><name><surname>Pak</surname><given-names>TH</given-names></name><name><surname>Parry</surname><given-names>SE</given-names></name><name><surname>Pathak</surname><given-names>SD</given-names></name><name><surname>Pearson</surname><given-names>OC</given-names></name><name><surname>Puchalski</surname><given-names>RB</given-names></name><name><surname>Riley</surname><given-names>ZL</given-names></name><name><surname>Rockett</surname><given-names>HR</given-names></name><name><surname>Rowland</surname><given-names>SA</given-names></name><name><surname>Royall</surname><given-names>JJ</given-names></name><name><surname>Ruiz</surname><given-names>MJ</given-names></name><name><surname>Sarno</surname><given-names>NR</given-names></name><name><surname>Schaffnit</surname><given-names>K</given-names></name><name><surname>Shapovalova</surname><given-names>NV</given-names></name><name><surname>Sivisay</surname><given-names>T</given-names></name><name><surname>Slaughterbeck</surname><given-names>CR</given-names></name><name><surname>Smith</surname><given-names>SC</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Smith</surname><given-names>BI</given-names></name><name><surname>Sodt</surname><given-names>AJ</given-names></name><name><surname>Stewart</surname><given-names>NN</given-names></name><name><surname>Stumpf</surname><given-names>K-R</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Sutram</surname><given-names>M</given-names></name><name><surname>Tam</surname><given-names>A</given-names></name><name><surname>Teemer</surname><given-names>CD</given-names></name><name><surname>Thaller</surname><given-names>C</given-names></name><name><surname>Thompson</surname><given-names>CL</given-names></name><name><surname>Varnam</surname><given-names>LR</given-names></name><name><surname>Visel</surname><given-names>A</given-names></name><name><surname>Whitlock</surname><given-names>RM</given-names></name><name><surname>Wohnoutka</surname><given-names>PE</given-names></name><name><surname>Wolkey</surname><given-names>CK</given-names></name><name><surname>Wong</surname><given-names>VY</given-names></name><name><surname>Wood</surname><given-names>M</given-names></name><name><surname>Yaylaoglu</surname><given-names>MB</given-names></name><name><surname>Young</surname><given-names>RC</given-names></name><name><surname>Youngstrom</surname><given-names>BL</given-names></name><name><surname>Yuan</surname><given-names>XF</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zwingman</surname><given-names>TA</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genome-Wide atlas of gene expression in the adult mouse brain</article-title><source>Nature</source><volume>445</volume><fpage>168</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1038/nature05453</pub-id><pub-id pub-id-type="pmid">17151600</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>G</given-names></name><name><surname>Onaka</surname><given-names>T</given-names></name><name><surname>Caquineau</surname><given-names>C</given-names></name><name><surname>Sabatier</surname><given-names>N</given-names></name><name><surname>Tobin</surname><given-names>VA</given-names></name><name><surname>Takayanagi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oxytocin and appetite</article-title><source>Progress in Brain Research</source><volume>170</volume><fpage>137</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/S0079-6123(08)00413-5</pub-id><pub-id pub-id-type="pmid">18655879</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>G</given-names></name><name><surname>Sabatier</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Oxytocin-the sweet hormone?</article-title><source>Trends in Endocrinology and Metabolism</source><volume>28</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2017.02.007</pub-id><pub-id pub-id-type="pmid">28283319</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PTC-bearing mRNA elicits a genetic compensation response via upf3a and COMPASS components</article-title><source>Nature</source><volume>568</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1057-y</pub-id><pub-id pub-id-type="pmid">30944473</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maejima</surname><given-names>Y</given-names></name><name><surname>Iwasaki</surname><given-names>Y</given-names></name><name><surname>Yamahara</surname><given-names>Y</given-names></name><name><surname>Kodaira</surname><given-names>M</given-names></name><name><surname>Sedbazar</surname><given-names>U</given-names></name><name><surname>Yada</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass</article-title><source>Aging</source><volume>3</volume><fpage>1169</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.18632/aging.100408</pub-id><pub-id pub-id-type="pmid">22184277</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maejima</surname><given-names>Y</given-names></name><name><surname>Sakuma</surname><given-names>K</given-names></name><name><surname>Santoso</surname><given-names>P</given-names></name><name><surname>Gantulga</surname><given-names>D</given-names></name><name><surname>Katsurada</surname><given-names>K</given-names></name><name><surname>Ueta</surname><given-names>Y</given-names></name><name><surname>Hiraoka</surname><given-names>Y</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name><name><surname>Yada</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Oxytocinergic circuit from paraventricular and supraoptic nuclei to arcuate POMC neurons in hypothalamus</article-title><source>FEBS Letters</source><volume>588</volume><fpage>4404</fpage><lpage>4412</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2014.10.010</pub-id><pub-id pub-id-type="pmid">25448678</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maejima</surname><given-names>Y</given-names></name><name><surname>Yokota</surname><given-names>S</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The anorexigenic neural pathways of oxytocin and their clinical implication</article-title><source>Neuroendocrinology</source><volume>107</volume><fpage>91</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1159/000489263</pub-id><pub-id pub-id-type="pmid">29660735</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitre</surname><given-names>M</given-names></name><name><surname>Marlin</surname><given-names>BJ</given-names></name><name><surname>Schiavo</surname><given-names>JK</given-names></name><name><surname>Morina</surname><given-names>E</given-names></name><name><surname>Norden</surname><given-names>SE</given-names></name><name><surname>Hackett</surname><given-names>TA</given-names></name><name><surname>Aoki</surname><given-names>CJ</given-names></name><name><surname>Chao</surname><given-names>MV</given-names></name><name><surname>Froemke</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A distributed network for social cognition enriched for oxytocin receptors</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>2517</fpage><lpage>2535</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2409-15.2016</pub-id><pub-id pub-id-type="pmid">26911697</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>NCD Risk Factor Collaboration</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants</article-title><source>Lancet</source><volume>387</volume><fpage>1377</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)30054-X</pub-id><pub-id pub-id-type="pmid">27115820</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newmaster</surname><given-names>KT</given-names></name><name><surname>Nolan</surname><given-names>ZT</given-names></name><name><surname>Chon</surname><given-names>U</given-names></name><name><surname>Vanselow</surname><given-names>DJ</given-names></name><name><surname>Weit</surname><given-names>AR</given-names></name><name><surname>Tabbaa</surname><given-names>M</given-names></name><name><surname>Hidema</surname><given-names>S</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Hammock</surname><given-names>EAD</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Quantitative cellular-resolution map of the oxytocin receptor in postnatally developing mouse brains</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1885</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-15659-1</pub-id><pub-id pub-id-type="pmid">32313029</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ollmann</surname><given-names>MM</given-names></name><name><surname>Wilson</surname><given-names>BD</given-names></name><name><surname>Yang</surname><given-names>YK</given-names></name><name><surname>Kerns</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gantz</surname><given-names>I</given-names></name><name><surname>Barsh</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein</article-title><source>Science</source><volume>278</volume><fpage>135</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1126/science.278.5335.135</pub-id><pub-id pub-id-type="pmid">9311920</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaka</surname><given-names>T</given-names></name><name><surname>Takayanagi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Role of oxytocin in the control of stress and food intake</article-title><source>Journal of Neuroendocrinology</source><volume>31</volume><elocation-id>e12700</elocation-id><pub-id pub-id-type="doi">10.1111/jne.12700</pub-id><pub-id pub-id-type="pmid">30786104</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>ZY</given-names></name><name><surname>Bongiorno</surname><given-names>DM</given-names></name><name><surname>Hernando</surname><given-names>MA</given-names></name><name><surname>Grill</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Effects of endogenous oxytocin receptor signaling in nucleus tractus solitarius on satiation-mediated feeding and thermogenic control in male rats</article-title><source>Endocrinology</source><volume>158</volume><fpage>2826</fpage><lpage>2836</lpage><pub-id pub-id-type="doi">10.1210/en.2017-00200</pub-id><pub-id pub-id-type="pmid">28575174</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oti</surname><given-names>T</given-names></name><name><surname>Satoh</surname><given-names>K</given-names></name><name><surname>Uta</surname><given-names>D</given-names></name><name><surname>Nagafuchi</surname><given-names>J</given-names></name><name><surname>Tateishi</surname><given-names>S</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Takanami</surname><given-names>K</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>JF</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Sakamoto</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Oxytocin influences male sexual activity via non-synaptic axonal release in the spinal cord</article-title><source>Current Biology</source><volume>31</volume><fpage>103</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.09.089</pub-id><pub-id pub-id-type="pmid">33125871</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>L</given-names></name><name><surname>Lozic</surname><given-names>M</given-names></name><name><surname>Allchorne</surname><given-names>A</given-names></name><name><surname>Grinevich</surname><given-names>V</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Identification of peripheral oxytocin-expressing cells using systemically applied cell-type specific adeno-associated viral vector</article-title><source>Journal of Neuroendocrinology</source><volume>33</volume><elocation-id>e12970</elocation-id><pub-id pub-id-type="doi">10.1111/jne.12970</pub-id><pub-id pub-id-type="pmid">33851744</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Geng</surname><given-names>L</given-names></name><name><surname>Mei</surname><given-names>L</given-names></name><name><surname>Osakada</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Kania</surname><given-names>A</given-names></name><name><surname>Grinevich</surname><given-names>V</given-names></name><name><surname>Stoop</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Compartmental Neuropeptide Release Measured Using a New Oxytocin Sensor</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.02.10.480016</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>M</given-names></name><name><surname>Braida</surname><given-names>D</given-names></name><name><surname>Donzelli</surname><given-names>A</given-names></name><name><surname>Martucci</surname><given-names>R</given-names></name><name><surname>Busnelli</surname><given-names>M</given-names></name><name><surname>Bulgheroni</surname><given-names>E</given-names></name><name><surname>Rubino</surname><given-names>T</given-names></name><name><surname>Parolaro</surname><given-names>D</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Chini</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mice heterozygous for the oxytocin receptor gene (OXTR (+/-)) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect</article-title><source>Journal of Neuroendocrinology</source><volume>25</volume><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2826.2012.02385.x</pub-id><pub-id pub-id-type="pmid">22967062</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Hamasaki</surname><given-names>Y</given-names></name><name><surname>Fukui</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Minami</surname><given-names>M</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Amygdalohippocampal area neurons that project to the preoptic area mediate infant-directed attack in male mice</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>3981</fpage><lpage>3994</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0438-19.2020</pub-id><pub-id pub-id-type="pmid">32284340</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shor-Posner</surname><given-names>G</given-names></name><name><surname>Azar</surname><given-names>AP</given-names></name><name><surname>Insinga</surname><given-names>S</given-names></name><name><surname>Leibowitz</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Deficits in the control of food intake after hypothalamic paraventricular nucleus lesions</article-title><source>Physiology &amp; Behavior</source><volume>35</volume><fpage>883</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/0031-9384(85)90255-0</pub-id><pub-id pub-id-type="pmid">3006098</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>JS</given-names></name><name><surname>Lorden</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Effect of paraventricular nucleus lesions on body weight, food intake and insulin levels</article-title><source>Behavioural Brain Research</source><volume>22</volume><fpage>265</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/0166-4328(86)90071-9</pub-id><pub-id pub-id-type="pmid">3098259</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stachniak</surname><given-names>TJ</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Sternson</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chemogenetic synaptic silencing of neural circuits localizes a hypothalamus→midbrain pathway for feeding behavior</article-title><source>Neuron</source><volume>82</volume><fpage>797</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.04.008</pub-id><pub-id pub-id-type="pmid">24768300</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sternson</surname><given-names>SM</given-names></name><name><surname>Eiselt</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Three pillars for the neural control of appetite</article-title><source>Annual Review of Physiology</source><volume>79</volume><fpage>401</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021115-104948</pub-id><pub-id pub-id-type="pmid">27912679</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>AK</given-names></name><name><surname>Myers</surname><given-names>MG</given-names></name><name><surname>Olson</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The role of PVH circuits in leptin action and energy balance</article-title><source>Annual Review of Physiology</source><volume>78</volume><fpage>207</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021115-105347</pub-id><pub-id pub-id-type="pmid">26863324</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayanagi</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Bielsky</surname><given-names>IF</given-names></name><name><surname>Ross</surname><given-names>HE</given-names></name><name><surname>Kawamata</surname><given-names>M</given-names></name><name><surname>Onaka</surname><given-names>T</given-names></name><name><surname>Yanagisawa</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice</article-title><source>PNAS</source><volume>102</volume><fpage>16096</fpage><lpage>16101</lpage><pub-id pub-id-type="doi">10.1073/pnas.0505312102</pub-id><pub-id pub-id-type="pmid">16249339</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayanagi</surname><given-names>Y</given-names></name><name><surname>Kasahara</surname><given-names>Y</given-names></name><name><surname>Onaka</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Kawada</surname><given-names>T</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oxytocin receptor-deficient mice developed late-onset obesity</article-title><source>Neuroreport</source><volume>19</volume><fpage>951</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1097/WNR.0b013e3283021ca9</pub-id><pub-id pub-id-type="pmid">18520999</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thienel</surname><given-names>M</given-names></name><name><surname>Fritsche</surname><given-names>A</given-names></name><name><surname>Heinrichs</surname><given-names>M</given-names></name><name><surname>Peter</surname><given-names>A</given-names></name><name><surname>Ewers</surname><given-names>M</given-names></name><name><surname>Lehnert</surname><given-names>H</given-names></name><name><surname>Born</surname><given-names>J</given-names></name><name><surname>Hallschmid</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oxytocin’s inhibitory effect on food intake is stronger in obese than normal-weight men</article-title><source>International Journal of Obesity</source><volume>40</volume><fpage>1707</fpage><lpage>1714</lpage><pub-id pub-id-type="doi">10.1038/ijo.2016.149</pub-id><pub-id pub-id-type="pmid">27553712</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viskaitis</surname><given-names>P</given-names></name><name><surname>Irvine</surname><given-names>EE</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Choudhury</surname><given-names>AI</given-names></name><name><surname>Alvarez-Curto</surname><given-names>E</given-names></name><name><surname>Glegola</surname><given-names>JA</given-names></name><name><surname>Hardy</surname><given-names>DG</given-names></name><name><surname>Pedroni</surname><given-names>SMA</given-names></name><name><surname>Paiva Pessoa</surname><given-names>MR</given-names></name><name><surname>Fernando</surname><given-names>ABP</given-names></name><name><surname>Katsouri</surname><given-names>L</given-names></name><name><surname>Sardini</surname><given-names>A</given-names></name><name><surname>Ungless</surname><given-names>MA</given-names></name><name><surname>Milligan</surname><given-names>G</given-names></name><name><surname>Withers</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Modulation of SF1 neuron activity coordinately regulates both feeding behavior and associated emotional states</article-title><source>Cell Reports</source><volume>21</volume><fpage>3559</fpage><lpage>3572</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.11.089</pub-id><pub-id pub-id-type="pmid">29262334</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Flanagan</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>LC</given-names></name><name><surname>Bui</surname><given-names>S</given-names></name><name><surname>Nielson</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Vo</surname><given-names>HT</given-names></name><name><surname>Ma</surname><given-names>XJ</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues</article-title><source>The Journal of Molecular Diagnostics</source><volume>14</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.jmoldx.2011.08.002</pub-id><pub-id pub-id-type="pmid">22166544</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worth</surname><given-names>AA</given-names></name><name><surname>Luckman</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Do oxytocin neurones affect feeding?</article-title><source>Journal of Neuroendocrinology</source><volume>33</volume><elocation-id>e13035</elocation-id><pub-id pub-id-type="doi">10.1111/jne.13035</pub-id><pub-id pub-id-type="pmid">34495565</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Clark</surname><given-names>MS</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Deciphering a neuronal circuit that mediates appetite</article-title><source>Nature</source><volume>483</volume><fpage>594</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1038/nature10899</pub-id><pub-id pub-id-type="pmid">22419158</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Sutton</surname><given-names>AK</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Olson</surname><given-names>DP</given-names></name><name><surname>Tong</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>An obligate role of oxytocin neurons in diet induced energy expenditure</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e45167</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0045167</pub-id><pub-id pub-id-type="pmid">23028821</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Bergan</surname><given-names>J</given-names></name><name><surname>Lanjuin</surname><given-names>A</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Oxytocin signaling in the medial amygdala is required for sex discrimination of social cues</article-title><source>eLife</source><volume>6</volume><elocation-id>e31373</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.31373</pub-id><pub-id pub-id-type="pmid">29231812</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yulyaningsih</surname><given-names>E</given-names></name><name><surname>Rudenko</surname><given-names>IA</given-names></name><name><surname>Valdearcos</surname><given-names>M</given-names></name><name><surname>Dahlén</surname><given-names>E</given-names></name><name><surname>Vagena</surname><given-names>E</given-names></name><name><surname>Chan</surname><given-names>A</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name><name><surname>Vaisse</surname><given-names>C</given-names></name><name><surname>Koliwad</surname><given-names>SK</given-names></name><name><surname>Xu</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Acute lesioning and rapid repair of hypothalamic neurons outside the blood-brain barrier</article-title><source>Cell Reports</source><volume>19</volume><fpage>2257</fpage><lpage>2271</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.05.060</pub-id><pub-id pub-id-type="pmid">28614713</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Qiu</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Ni</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Mai</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Bao</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Reconstruction of the hypothalamo-neurohypophysial system and functional dissection of magnocellular oxytocin neurons in the brain</article-title><source>Neuron</source><volume>109</volume><fpage>331</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.10.032</pub-id><pub-id pub-id-type="pmid">33212012</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75718.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Elmquist</surname><given-names>Joel K</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.11.29.470473" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.11.29.470473"/></front-stub><body><p>Inada and colleagues report results from a series of studies investigating the role of the neuropeptide oxytocin in regulating food intake and body weight. They used combinations of genetics and behavioral studies to demonstrate that oxytocin deletion results in increased food intake and body weight. They further show that deletion of the oxytocin receptor in the posterior hypothalamus causes a similar increase in food intake and body weight. Collectively, these studies support a role for the oxytocin system as a key regulator of energy balance.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75718.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Elmquist</surname><given-names>Joel K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.11.29.470473">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.11.29.470473v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Oxytocin signaling in the posterior hypothalamus prevents hyperphagic obesity in mice&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Ma-Li Wong as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The reviewers agree that several technical issues outlined below need to be addressed. In particular, the authors should address the sample sizes noted below.</p><p>In addition, more precise description of the anatomic details is needed throughout the manuscript.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>(1) It is not clear the reason behind using the partial conditional KO mice, OTflox/-. Could you explain why flox/KO was used instead of flox/flox model? If so, these mice are &quot;partial&quot; conditional KO model instead of &quot;bona fida&quot; conditional KO, aren't they? The authors need to clarify this model.</p><p>(2) Regarding Figure 4, previous literature has shown that OT injection reduces food intake within an hour. Does OT injection into OT knockout in the PVH mice have the same effect? It is important as these type of experiments can point out that OT may be required for transcriptional changes and/or circuit re-wiring (and others) to regulate food intake.</p><p>(3) A large body of studies have shown that the ventrolateral side of the ventromedial hypothalamic nucleus (VMHvl) regulates food intake. In addition, recent optogenetic and chemogenetic studies have shown that the dorsomedial and center part of VMH (VMHdm/c) also can regulate food intake, although many genetic studies (e.g., knockout the important genes such as leptin receptors from the VMHdm/c) do not support this notion. The authors pinpointed that the phenotype in Figure 5 resulted from the ablation of OTR in the arcuate hypothalamic nucleus (ARH) and/or the lateral hypothalamic area (LHA). However, Cre-GFP expression was strongly observed throughout the VMH (Figure 5D). The authors may want to discuss/address the possibility that OTR in the VMH may be involved in OT-induced food suppression effects.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is a straightforward and important study investigating the role of oxytocin signaling on appetite and body weight. By loss of function in adult mice, the authors show a clear role for oxytocin as a inhibitory molecule for overeating.</p><p>The major critiques of the study are</p><p>1. The sample sizes are typically too small (often n=4), especially in Figure 4 where the effect sizes are smaller.</p><p>2. The authors have not ruled out the possibility that viral overexpression of Cre in the PVH is responsible for the hyperphagia. Testing this in the OT-/- and in OT+/+ mice would be prudent. There is no information about the viral titer or surgical procedures, but I suspect high viral titers were sued, which could non-specifically reduced PVH function.</p><p>3. The fraction of neurons reported to be OXTR+ seems too high. The authors should determine the background rate of OXTR detection in OXTR-/- mice or in regions known not to expression OXTR and use this a threshold for OXTR expression vs noise e.g., lipofuscin can show up as a false positive in RNAscope and this is determined by measuring if the spot shows broadband fluorescence at other wavelengths.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The manuscript by Inada et al. examines the role of hypothalamic oxytocin (OT) signaling in feeding behavior. They demonstrate that conditional knockout of OT in the adult paraventricular hypothalamic nucleus (PVH) increases body weight through increases in food intake, and that conditional knockout of the OT receptor in the posterior hypothalamus has a similar effect. The authors therefore conclude that OT signaling in the posterior hypothalamus, presumably through oxytocin produced in the PVH, contributes to energy balance control.</p><p>Strengths:</p><p>There has been conflicting literature on the role of OT in feeding behavior. Although pharmacological and genetic approaches have suggested an anorexic effect of OT, knockout of OT or OT receptor has minimal effect on feeding. To address this apparent discrepancy, the authors use conditional knockout models to manipulate OT signaling. This allows not only temporal control of OT and OT receptor, but also allows investigation of signaling in different brain regions (versus, for example, whole body or organ). That the conditional knockout mice display hyperphagia and obesity begins to settle this conflict in the literature.</p><p>Weaknesses:</p><p>1) There is not a major conceptual advance. The data largely confirm what pharmacological and RNAi knockdown studies have previously demonstrated.</p><p>2) The finding that IP injection of OT partially rescues the phenotype of the KO mouse lacks rigor and proper controls.</p><p>• Only one dose of OT was used.</p><p>• The effect of IP OT in WT mice should be shown. If the IP OT reduces food intake in the WT mouse, then it could be an independent effect.</p><p>• Injection of OT within regions of the hypothalamus would provide more information about the localization of these effects.</p><p>• How do the authors reconcile the fact that there is no effect on feeding behavior but an effect on body weight, especially when the OT KO has a feeding phenotype?</p><p>3) There is little anatomical precision in the manipulation of OT receptors in the posterior hypothalamus.&quot; Understanding which of these brain regions (e.g. ARH, VMH, LHA, DMH, others?) is involved in mediating these effects would be very helpful. It is also a missed opportunity to not explore hindbrain OT receptor, as this would be a good positive control (previous literature).</p><p>4) Attempts to connect the OT KO data with the OT receptor KO data would greatly enhance this manuscript by delineating a circuit mechanism for central OT-induced anorexia. This could be achieved by giving central injections of OT into target regions of OT KO mice, for example.</p><p>Other comments:</p><p>1) Unless I am mistaken, the authors cite a biorxiv paper for the &quot;previously-validated&quot; mouse, but this has not been peer reviewed.</p><p>2) What dose of OT was used in Figure 4? Please provide in g.</p><p>3) How was food intake measured?</p><p>4) The authors say in the text that the changes in the weight of the viscera and the blood constituents were independent of body weight. However, the legend says that these measurements were taken 5 weeks post injection, and Figure 1 shows a clear BW phenotype at 5 weeks post-injection. Please clarify.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75718.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The reviewers agree that several technical issues outlined below need to be addressed. In particular, the authors should address the sample sizes noted below.</p><p>In addition, more precise description of the anatomic details is needed throughout the manuscript.</p><p>Reviewer #1 (Recommendations for the authors):</p><p>(1) It is not clear the reason behind using the partial conditional KO mice, OTflox/-. Could you explain why flox/KO was used instead of flox/flox model? If so, these mice are &quot;partial&quot; conditional KO model instead of &quot;bona fida&quot; conditional KO, aren't they? The authors need to clarify this model.</p></disp-quote><p>We thank the reviewer for the positive evaluation of our main aims and conclusions, and for very constructive suggestions. We chose the Oxt flox/null model to increase the efficiency of Cre-mediated KO. If we had used Oxt flox/flox mice, which have very high Oxt gene expression levels, a small fraction of the flox alleles that do not experience recombination would easily mask the body weight and feeding phenotypes. Because flox/null alone (without Cre) has no phenotype (Figure 1F), we could justify the use of the flox/null model. In principle, this situation is comparable to analyzing homozygous mutants by using heterozygotes as a reference, which is common in the genetics of mice and flies. In addition, many influential papers have utilized flox/null models as conditional knockout (for example, Kwan et al. Genesis 39, 10, 2004; Pelosi et al., Plos One 10: e0136422, 2015). In the revised manuscript, we added additional explanations in the Materials and methods to clarify our thoughts (lines 312–318). Regarding Oxtr conditional knockout, we chose the flox/flox model because the haploinsufficiency gene effect of Oxtr has been reported, at least in the context of social behaviors (Sala et al. J Neuroendocrinology 25, 107, 2013).</p><disp-quote content-type="editor-comment"><p>(2) Regarding Figure 4, previous literature has shown that OT injection reduces food intake within an hour. Does OT injection into OT knockout in the PVH mice have the same effect? It is important as these type of experiments can point out that OT may be required for transcriptional changes and/or circuit re-wiring (and others) to regulate food intake.</p></disp-quote><p>We deeply appreciate this important comment. According to this suggestion, we conducted a new experiment to test the short-term effect of IP injection of Oxt. We found that Oxt cKO mice ate significantly less after 1, 3, and 5 hours of Oxt IP injection, consistent with previous literature using wild-type rats or mice. We reported these data in new Figure 4—figure supplement 1E–H.</p><disp-quote content-type="editor-comment"><p>(3) A large body of studies have shown that the ventrolateral side of the ventromedial hypothalamic nucleus (VMHvl) regulates food intake. In addition, recent optogenetic and chemogenetic studies have shown that the dorsomedial and center part of VMH (VMHdm/c) also can regulate food intake, although many genetic studies (e.g., knockout the important genes such as leptin receptors from the VMHdm/c) do not support this notion. The authors pinpointed that the phenotype in Figure 5 resulted from the ablation of OTR in the arcuate hypothalamic nucleus (ARH) and/or the lateral hypothalamic area (LHA). However, Cre-GFP expression was strongly observed throughout the VMH (Figure 5D). The authors may want to discuss/address the possibility that OTR in the VMH may be involved in OT-induced food suppression effects.</p></disp-quote><p>We are greatly thankful for this important comment. We have conducted additional experiments to remove the Oxtr gene with a high spatial resolution (now reported in new Figure 6). To achieve this, we injected serotype 2 of AAV-Cre into the ARH or LHA. As expected, Oxtr expression in the targeted nucleus was significantly reduced, while that in the VMH, a neighboring nucleus, was unaffected (Figure 6E and 6F). We also found an increase in food intake and body weight after injecting the AAV into the ARH, but not into the LHA. Still, these results do not rule out the possibility that VMH contributes to the suppression of hyperphagic obesity. Nevertheless, we appreciate the importance of VMH for feeding regulation and added a discussion regarding VMH in the revised manuscript (lines 278–280).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This is a straightforward and important study investigating the role of oxytocin signaling on appetite and body weight. By loss of function in adult mice, the authors show a clear role for oxytocin as a inhibitory molecule for overeating.</p><p>The critiques of the study are</p><p>1. The sample sizes are typically too small (often n=4), especially in Figure 4 where the effect sizes are smaller.</p></disp-quote><p>We are greatly thankful to this reviewer for the positive evaluation of our main aims and conclusions, as well as for the very constructive suggestions. As described in the revised manuscript, we have included additional cohorts of Oxt cKO (Figure 1) and IP injection of Oxt (Figure 4) to collect enough animals. In addition, in Figure 4, we added different doses of Oxt IP injection, which further strengthens our initial conclusion.</p><disp-quote content-type="editor-comment"><p>2. The authors have not ruled out the possibility that viral overexpression of Cre in the PVH is responsible for the hyperphagia. Testing this in the OT-/- and in OT+/+ mice would be prudent. There is no information about the viral titer or surgical procedures, but I suspect high viral titers were sued, which could non-specifically reduced PVH function.</p></disp-quote><p>We appreciate this important comment. According to this suggestion, we injected 200 nL of <italic>AAV</italic> serotype <italic>9 hSyn-Cre</italic> (2.3 x 10<sup>13</sup> genome particles/mL) into wild-type PVH. Neither body weight nor daily food intake measured at 5 weeks after the injection differed from the saline-injected control. This result is reported in new Figure 1—figure supplement 1, and the experimental conditions are described in the Materials and methods.</p><disp-quote content-type="editor-comment"><p>3. The fraction of neurons reported to be OXTR+ seems too high. The authors should determine the background rate of OXTR detection in OXTR-/- mice or in regions known not to expression OXTR and use this a threshold for OXTR expression vs noise e.g., lipofuscin can show up as a false positive in RNAscope and this is determined by measuring if the spot shows broadband fluorescence at other wavelengths.</p></disp-quote><p>We sincerely thank the reviewer for this important comment. We newly generated <italic>Oxtr<sup>–/–</sup></italic> mice by injecting Cre mRNA into Oxtr flox/flox zygotes to conduct negative control experiments of RNAscope assay. In agreement with the concern raised by the reviewer, 1 or 2 RNAscope dots were detected in approximately 25% of DAPI+ cells of <italic>Oxtr<sup>–/–</sup></italic> mice, as reported in new Figure 5—figure supplement 1. This means that Figure 5 of our initial manuscript contained a substantial fraction of pseudo-positive detection of Oxtr. Because we found that defining Oxtr+ cells as a DAPI+ cell with three or more dots provides a near-zero ratio (less than 5%) of pseudo-positive detection of Oxtr+ cells in <italic>Oxtr<sup>–/–</sup></italic> mice (Figure 5—figure supplement 2), we applied this new definition throughout the paper (Figures 5 and 6). Regardless of this revised definition, our conclusion remains the same, given that AAV-Cre injection into Oxtr<sup>flox/flox</sup> mice significantly reduced the number of Oxtr+ cells (Figures 5 and 6).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The manuscript by Inada et al. examines the role of hypothalamic oxytocin (OT) signaling in feeding behavior. They demonstrate that conditional knockout of OT in the adult paraventricular hypothalamic nucleus (PVH) increases body weight through increases in food intake, and that conditional knockout of the OT receptor in the posterior hypothalamus has a similar effect. The authors therefore conclude that OT signaling in the posterior hypothalamus, presumably through oxytocin produced in the PVH, contributes to energy balance control.</p><p>Strengths:</p><p>There has been conflicting literature on the role of OT in feeding behavior. Although pharmacological and genetic approaches have suggested an anorexic effect of OT, knockout of OT or OT receptor has minimal effect on feeding. To address this apparent discrepancy, the authors use conditional knockout models to manipulate OT signaling. This allows not only temporal control of OT and OT receptor, but also allows investigation of signaling in different brain regions (versus, for example, whole body or organ). That the conditional knockout mice display hyperphagia and obesity begins to settle this conflict in the literature.</p><p>Weaknesses:</p><p>1) There is not a major conceptual advance. The data largely confirm what pharmacological and RNAi knockdown studies have previously demonstrated.</p></disp-quote><p>We are sincerely thankful to this reviewer for the positive evaluation of our main aims and conclusions, as well as for the very constructive suggestions. We agree with the view that the main aim of this study is to resolve the conflict between genetic mutant and pharmacological/knockdown studies. However, in the revised manuscript, we have provided additional evidence that OxtR signaling, specifically in the arcuate nucleus, is responsible for suppressing hyperphagia (as reported in new Figure 6). We think that the demonstration of such functional localization of Oxt-OxtR signaling can provide some biological advances, as it cannot be achieved easily by classical pharmacology.</p><disp-quote content-type="editor-comment"><p>2) The finding that IP injection of OT partially rescues the phenotype of the KO mouse lacks rigor and proper controls.</p><p>• Only one dose of OT was used.</p><p>• The effect of IP OT in WT mice should be shown. If the IP OT reduces food intake in the WT mouse, then it could be an independent effect.</p><p>• Injection of OT within regions of the hypothalamus would provide more information about the localization of these effects.</p><p>• How do the authors reconcile the fact that there is no effect on feeding behavior but an effect on body weight, especially when the OT KO has a feeding phenotype?</p></disp-quote><p>We are also thankful for this important comment. According to these suggestions, we have included an additional cohort of IP injection of Oxt into Oxt cKO mice to test different doses of Oxt, as reported in Figure 4 in the revised manuscript. Both 50.36 µg and 100.72 µg per injection significantly reduced body weight and food intake in Oxt cKO mice. Importantly, IP injection of the same dose of Oxt into wild-type mice did not affect body weight or food intake, as reported in new Figure 4—figure supplement 1A–D. With the greater number of animals in multiple conditions, the reduced feeding by IP injection of Oxt is more explicitly shown in the revised manuscript. Still, the plasma triglyceride and leptin concentrations were not fully rescued by IP injection of Oxt in Oxt cKO mice, suggesting that the Oxt provided via IP injection is somehow suboptimal in regard to its effect site in the body and/or brain.</p><p>Regarding the functional identification of the effective site of Oxt, we decided to conduct local cKO of Oxtr (see response to Reviewer3, point 3 below) instead of local infusion of Oxt into the target brain regions (such as ARH). This is because (i) it is generally difficult to evaluate the diffusion of a solution containing Oxt after local infusion, and (ii) animals need to be anesthetized repeatedly for local infusion of Oxt through a guide cannula, which by itself could affect their feeding patterns.</p><disp-quote content-type="editor-comment"><p>3) There is little anatomical precision in the manipulation of OT receptors in the posterior hypothalamus.&quot; Understanding which of these brain regions (e.g. ARH, VMH, LHA, DMH, others?) is involved in mediating these effects would be very helpful. It is also a missed opportunity to not explore hindbrain OT receptor, as this would be a good positive control (previous literature).</p></disp-quote><p>We appreciate this comment. Although precisely controlling Cre activity at the resolution of a single anatomical structure in the brain is not trivial, by using AAV serotype 2, which tends to spread less around the injection site, we conducted ARH- and LHA-specific loss-of-function of Oxtr (new Figure 6). We found that body weight, daily food intake, and cumulative food intake were significantly larger in the mice that received AAV-Cre injection into the ARH, whereas no significant difference was found in the mice that expressed Cre into the LHA. Although we do not exclude the contribution of Oxtr in other brain regions, these data suggest that the majority of effects given rise to by Oxtr cKO in the posterior hypothalamus can be explained by the reduction of Oxtr expression in the ARH.</p><disp-quote content-type="editor-comment"><p>4) Attempts to connect the OT KO data with the OT receptor KO data would greatly enhance this manuscript by delineating a circuit mechanism for central OT-induced anorexia. This could be achieved by giving central injections of OT into target regions of OT KO mice, for example.</p></disp-quote><p>We agree with this view that a circuit mechanism by which PVH Oxt neurons are linked to the posterior hypothalamus Oxtr-expressing neurons would strengthen the manuscript. However, it is highly challenging to pinpoint the site of Oxt release for preventing hyperphagia. Although our Oxtr cKO in the ARH (Figure 6) improved the spatial resolution of the site of Oxt action, this Oxtr signaling may be mediated by diffusion of Oxt from long range, such as cell bodies/dendrites in the PVH or Oxt-positive fibers elsewhere in the brain, rather than direct axonal projection from PVH Oxt neurons to the ARH. As IP-injected Oxt is also functional (Figure 4), in principle, it is possible that circulating Oxt in the bloodstream is responsible for the Oxt signaling in the ARH, presumably via a leaky blood–brain barrier or the tanycytic-mediated active transport of humoral signals. Future studies, including real-time imaging of Oxt ligand release by an Oxt sensor, would further reveal circuit mechanisms. In the revised manuscript, we have improved the spatial resolution of our Oxtr cKO (see our response #3-3). We have also mentioned that the suggested point is an important topic for future research in the Discussion (lines 293–295).</p><disp-quote content-type="editor-comment"><p>Other comments:</p><p>1) Unless I am mistaken, the authors cite a biorxiv paper for the &quot;previously-validated&quot; mouse, but this has not been peer reviewed.</p></disp-quote><p>We apologize that the citation was a preprint at the time of initial submission. During the revision, it was updated as follows.</p><p>Inada K et al., Neuron 110, 2009-2023.e5, 2022. https://pubmed.ncbi.nlm.nih.gov/35443152/.</p><p>We have also updated this citation in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2) What dose of OT was used in Figure 4? Please provide in g.</p></disp-quote><p>According to this comment, we added a description in Figure 4.</p><disp-quote content-type="editor-comment"><p>3) How was food intake measured?</p></disp-quote><p>We apologize that our description in the Materials and methods was not sufficient. In the revised manuscript, we have provided further details of the food intake measurements (lines 337–345).</p><disp-quote content-type="editor-comment"><p>4) The authors say in the text that the changes in the weight of the viscera and the blood constituents were independent of body weight. However, the legend says that these measurements were taken 5 weeks post injection, and Figure 1 shows a clear BW phenotype at 5 weeks post-injection. Please clarify.</p></disp-quote><p>We do not think that viscera and blood constituents are independent of body weight. We apologize that our initial description was unclear. We have clarified this in the revised manuscript (lines 155–158).</p></body></sub-article></article>